<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 1999
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________ to _______________
Commission file number 0-19147
COVENTRY HEALTH CARE, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 52-2073000
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
6705 ROCKLEDGE DRIVE, SUITE 900 BETHESDA, MD 20817
(Address of principal executive office) (Zip Code)
(301) 581-0600
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
YES X NO
---
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.
<TABLE>
<CAPTION>
Class Outstanding at October 31, 1999
- ----- -------------------------------
<S> <C>
Common Stock $.01 Par Value 59,213,414
</TABLE>
<PAGE> 2
COVENTRY HEALTH CARE, INC.
FORM 10-Q
TABLE OF CONTENTS
<TABLE>
<CAPTION>
Page
----
<S> <C> <C>
PART I. FINANCIAL INFORMATION
Item 1: Financial Statements
Condensed Consolidated Balance Sheets
at September 30, 1999 and December 31, 1998 1
Condensed Consolidated Statements of Operations
for the quarter and nine months ended September 30, 1999
and 1998 2
Condensed Consolidated Statements of Cash Flows
for the nine months ended September 30, 1999 and 1998 3
Notes to Condensed Consolidated Financial
Statements 4
Item 2: Management's Discussion and Analysis of Financial
Condition and Results of Operations 14
Item 3: Quantitative and Qualitative Disclosures
about Market Risk 30
PART II. OTHER INFORMATION
Item 1: Legal Proceedings 31
Items 2, 3, 4, and 5 32
Item 6: Exhibits and Reports on Form 8-K 32
Signatures 33
</TABLE>
<PAGE> 3
COVENTRY HEALTH CARE, INC.AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
<TABLE>
<CAPTION>
September 30, December 31,
1999 1998
------------- -------------
(unaudited)
<S> <C> <C>
ASSETS
Cash and cash equivalents $ 185,409 $ 405,323
Short-term investments 71,009 46,714
Accounts receivable, net 51,804 43,466
Other receivables 33,417 23,126
Deferred income taxes 65,521 65,583
Other current assets 4,945 6,993
------------- -------------
Total current assets 412,105 591,205
Long-term investments 293,209 162,546
Property and equipment, net 37,854 35,780
Goodwill and intangible assets, net 265,341 295,966
Other assets 6,488 5,731
------------- -------------
Total assets $ 1,014,997 $ 1,091,228
============= =============
LIABILITIES AND STOCKHOLDERS' EQUITY
Medical claim liabilities $ 282,734 $ 330,743
Other medical liabilities 59,811 73,079
Accounts payable and other accrued liabilities 101,156 115,717
Deferred revenue 20,374 46,414
------------- -------------
Total current liabilities 464,075 565,953
Convertible exchangeable subordinated notes -- 45,538
Long-term debt -- 781
Deferred tax liabilities 33,809 32,909
Other long-term liabilities 5,901 9,509
Stockholders' equity:
Preferred stock, $.01 par value; Series A,
convertible, 6,000,000 shares authorized;
4,709,545 shares issued and outstanding in 1999 47 --
Common stock, $.01 par value; 200,000,000 shares
authorized; 59,614,450 shares issued and 59,174,890
outstanding in 1999; and 59,287,454 shares issued
and 58,847,894 outstanding in 1998 596 593
Additional paid-in capital 527,435 476,429
Accumulated other comprehensive (loss) income (4,008) 794
Accumulated deficit (7,858) (36,278)
Treasury stock, at cost, 439,560 shares (5,000) (5,000)
------------- -------------
Total stockholders' equity 511,212 436,538
------------- -------------
Total liabilities and stockholders' equity $ 1,014,997 $ 1,091,228
============= =============
</TABLE>
See notes to condensed consolidated financial statements.
1
<PAGE> 4
COVENTRY HEALTH CARE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
<TABLE>
<CAPTION>
Quarter ended Nine months ended
September 30, September 30,
--------------------------- ---------------------------
1999 1998 1999 1998
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Operating revenues:
Managed care premiums $ 509,815 $ 568,280 $ 1,529,088 $ 1,454,022
Management services 20,074 24,998 60,479 53,269
----------- ----------- ----------- -----------
Total operating revenues 529,889 593,278 1,589,567 1,507,291
Operating expenses:
Health benefits 437,674 505,518 1,310,804 1,261,817
Selling, general and administrative 73,790 78,077 227,962 206,434
Depreciation and amortization 7,034 7,504 21,079 18,141
AHERF charge -- -- -- 55,000
Merger costs -- -- -- 7,780
----------- ----------- ----------- -----------
Total operating expenses 518,498 591,099 1,559,845 1,549,172
Operating earnings (loss) 11,391 2,179 29,722 (41,881)
Other income, net of interest expense 7,805 5,809 20,578 13,113
----------- ----------- ----------- -----------
Earnings (loss) before income taxes 19,196 7,988 50,300 (28,768)
Provision for (benefit from) income
taxes 8,226 2,920 21,880 (10,787)
----------- ----------- ----------- -----------
Net earnings (loss) $ 10,970 $ 5,068 $ 28,420 $ (17,981)
----------- ----------- ----------- -----------
Net earnings (loss) per share
Basic $ 0.19 $ 0.09 $ 0.48 $ (0.36)
----------- ----------- ----------- -----------
Diluted $ 0.17 $ 0.09 $ 0.46 $ --
----------- ----------- ----------- -----------
</TABLE>
See notes to condensed consolidated financial statements.
2
<PAGE> 5
COVENTRY HEALTH CARE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
<TABLE>
<CAPTION>
Nine months ended
September 30,
-------------------------
1999 1998
----------- ------------
<S> <C> <C>
Net cash (used in) provided by operating activities $ (66,759) $ 22,606
----------- ------------
Cash flows from investing activities:
Capital expenditures, net (8,999) (8,249)
Net proceeds from sale of intangibles 12,841 --
Sale of investments 171,863 85,093
Purchase of investments (331,397) (94,044)
Cash acquired with purchase of PHC -- 148,600
----------- ------------
Net cash (used in) provided by investing activities (155,692) 131,400
----------- ------------
Cash flows from financing acitivities:
Issuance of long-term debt and notes payable -- 2,478
Payments of long-term debt and notes payable (829) (1,797)
Net proceeds from issuance of stock and warrants 3,366 1,415
----------- ------------
Net cash provided by financing activities 2,537 2,096
----------- ------------
Net (decrease) increase in cash and cash equivalents (219,914) 156,102
Cash and cash equivalents at beginning of
the period 405,323 153,979
----------- ------------
Cash and cash equivalents at end of the period $ 185,409 $ 310,081
=========== ============
Supplemental disclosures of cash flow information
Cash paid during the period was as follows:
Interest $ 25 $ 2,586
=========== ============
Income taxes $ 23,920 $ 13,600
=========== ============
</TABLE>
See notes to condensed consolidated financial statements.
3
<PAGE> 6
COVENTRY HEALTH CARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. BASIS OF PRESENTATION
The condensed consolidated financial statements of Coventry Health Care,
Inc. and subsidiaries ("Coventry" or "the Company") contained in this report
are unaudited but reflect all adjustments, consisting of normal recurring
adjustments which, in the opinion of management, are necessary for the fair
presentation of the results of the interim periods reflected. Certain
information and footnote disclosures normally included in the consolidated
financial statements prepared in accordance with generally accepted accounting
principles have been omitted pursuant to applicable rules and regulations of
the Securities and Exchange Commission (the "SEC"). The results of operations
for the interim periods reported herein are not necessarily indicative of
results to be expected for the full year. It is suggested that these condensed
consolidated financial statements be read in conjunction with the consolidated
financial statements and notes thereto included in the Company's most recent
Annual Report on Form 10-K for the year ended December 31, 1998, filed with the
SEC on March 30, 1999.
Certain 1998 amounts have been reclassified to conform to the 1999
presentation.
2. NEW ACCOUNTING STANDARDS
Derivative Instruments - In June 1998, the Financial Accounting Standards
Board ("FASB") issued Statement of Financial Accounting Standards No. 133 ("SFAS
133"), "Accounting for Derivative Instruments and Hedging Activities." SFAS 133
requires companies to record derivatives on the balance sheet as assets or
liabilities, measured at fair value. Gains or losses resulting from changes in
the values of the derivatives would be accounted for depending on the use of the
derivatives and whether they qualify for hedge accounting. SFAS 133 is effective
for fiscal years beginning after June 15, 2000. The Company does not believe
that adoption of SFAS 133 (as amended by SFAS 137) will have a material effect
on its future results of operations.
Computer Software - Effective January 1, 1999, the Company adopted
Statement of Position 98-1 ("SOP 98-1"), "Accounting for the Cost of Computer
Software Developed or Obtained for Internal Use" issued by the American
Institute of Certified Public Accountants ("AICPA"). SOP 98-1 provides
authoritative guidance for the capitalization of certain costs related to
computer software developed or obtained for internal applications, such as
external direct costs of materials and services, payroll costs for employees and
certain interest costs. Costs incurred during the preliminary project stage, as
well as training and data conversion costs, are to be expensed as incurred. SOP
98-1 is effective for fiscal years beginning after December 15, 1998. The
adoption of SOP 98-1 did not have a material effect on the Company's
consolidated financial statements.
4
<PAGE> 7
3. ACQUISITIONS AND DISPOSITIONS
Effective April 1, 1998, the Company completed its acquisition of certain
health plans of Principal Health Care, Inc. ("PHC") from Principal Mutual Life
Insurance Company, now known as Principal Life Insurance Company, ("Principal
Life") for a total purchase price of approximately $330.2 million including
transaction costs of approximately $5.7 million. The acquisition was accounted
for using the purchase method of accounting and, accordingly, the operating
results of PHC have been included in the Company's consolidated financial
statements since the date of acquisition. The purchase price consisted of
25,043,704 shares of the Company's common stock at an assigned value of $11.96
per share. In addition, a warrant valued at $25.0 million ("the Warrant") was
issued that grants Principal Life the right to acquire additional shares of the
Company's common stock in the event that its ownership percentage of such common
stock is diluted below 40%. The Warrant is included as a component of additional
paid-in capital in the accompanying condensed consolidated financial statements.
Through April 2003, Principal Life is restricted from buying additional shares
of the Company's common stock to increase its ownership percentage above 40%.
Coincident with the closing of the transaction, the Company entered into a
Marketing Services Agreement and a Management Services Agreement with Principal
Life. Both agreements extend through December 31, 1999. Pursuant to these
agreements, the Company recognized revenue of approximately $6.5 million for the
three months ended September 30, 1999, and $19.0 million for the nine months
ended September 30, 1999 and expects to receive payments of approximately $25.4
million during the year ended December 31, 1999, inclusive of the $19.0 million.
At the closing, the Company also entered into a Renewal Rights Agreement
and a Coinsurance Agreement with Principal Life, whereby the Company manages
certain of Principal Life's indemnity health insurance policies in the markets
where the Company does business and, on December 31, 1999, would offer to renew
such policies in force at that time. Effective June 1, 1999, the Company amended
these agreements with Principal Life and waived its rights to reinsure and renew
Principal Life's health insurance indemnity business located in the Company's
service area. The Company received $19.8 million in cash in exchange for waiving
these rights. At the date of the amendment, the Renewal Rights and Coinsurance
Agreements had a net book value of $19.7 million resulting in an after tax gain
of $0.1 million.
As a result of the acquisition, the Company assumed an agreement with
Principal Life, whereby Principal Life pays a fee for access to the Company's
preferred provider organization ("PPO") network based on a fixed rate per
employee entitled to access the PPO network and a percentage of savings realized
by Principal Life. Under this agreement, the Company recognized revenue of
approximately $2.0 million for the three months ended September 30, 1999 and
$6.0 million for the nine months ended September 30, 1999. The maximum amount
that can be paid under the percentage of savings component of the agreement is
$8.0 million for 1999.
Effective November 30, 1998, the Company sold its subsidiary, Principal
Health Care of Illinois, Inc., for $4.3 million in cash. The Illinois health
5
<PAGE> 8
plan accounted for approximately 56,000 risk members and approximately 2,400
non-risk members as of November 30, 1998.
On December 31, 1998, the Company sold its subsidiary, Principal Health
Care of Florida, Inc., for $95.0 million in cash. The Florida health plan
accounted for approximately 156,000 risk members and approximately 5,500 non-
risk members as of December 31, 1998.
The proceeds from both sales were used to retire the Company's credit
facility, to assist in improving the capital position of the Company's regulated
subsidiaries, and for other general corporate purposes. Given the short time
period between the respective acquisition and sale dates and the lack of events
or other evidence which would indicate differing values, no gain or loss was
recognized on the sales of the Florida and Illinois health plans, as the sale
prices were considered by management to be equivalent to the fair values
allocable to these plans at the date of their acquisition from Principal Life in
April 1998.
In connection with the acquisition of certain PHC health plans and the
sales of the Florida and Illinois plans, the Company established reserves of
approximately $33.0 million for the estimated transition costs of the PHC
health plans. These reserves are primarily comprised of severance costs related
to involuntary terminations of former PHC employees, relocation costs of former
PHC personnel, lease termination costs and contract termination costs. Through
September 30, 1999, the Company has expended approximately $28.0 million
related to these reserves and expects to make payments on the remaining
reserves through July 2002.
The purchase price for the PHC health plans, net of the impact of the
sales of the Florida and Illinois health plans and net of the impact of waiving
the Renewal Rights and Coinsurance Agreements, was allocated to the assets,
including the identifiable intangible assets, and liabilities based on
estimated fair values. The $180.2 million excess of purchase price over the net
identified tangible assets acquired was allocated to identifiable intangible
assets and goodwill. The allocated amounts and their related useful lives are
as follows:
<TABLE>
<CAPTION>
Amount
Description (in thousands) Useful Life
- -------------------------------------------------------------
<S> <C> <C>
Marketing Services Agreement $ 1,500 1.75 years
Customer Lists 7,233 5 years
HMO Licenses 10,000 20 years
Management Services Agreement 4,687 1.75 years
Goodwill 156,795 35 years
--------
Total $180,215
========
</TABLE>
4. CONVERTIBLE EXCHANGEABLE SUBORDINATED NOTES
During the quarter ended June 30, 1997, Coventry entered into a securities
purchase agreement with Warburg, Pincus Ventures, L.P. ("Warburg") and Franklin
Capital Associates III, L.P. ("Franklin") for the purchase of $40 million of
Coventry's 8.3% Convertible Exchangeable Senior Subordinated Notes ("Coventry
Notes"), together with warrants to purchase 2.35 million shares of Coventry's
common stock for $42.35 million. The Coventry Notes held by Warburg and
Franklin were convertible into Coventry's common stock
6
<PAGE> 9
and exchangeable at Coventry's or Warburg's option for shares of convertible
preferred stock. During the second and third quarters of 1999, Coventry
converted all Coventry Notes held by Franklin and Warburg, including interest,
into Series A convertible preferred stock. The second quarter conversion was
$4.7 million of notes into 473,705 shares and the third quarter conversion was
$42.4 million of notes into 4,235,840 shares.
5. COMPREHENSIVE INCOME (LOSS)
Comprehensive income (loss) is as follows (in thousands):
<TABLE>
<CAPTION>
Quarter ended
09/30/1999 09/30/1998
---------- ----------
<S> <C> <C>
Net income $ 10,970 $ 5,068
Other comprehensive income, net of tax:
Net unrealized (losses) gains on securities,
net of reclassification adjustment (722) 1,345
--------- ---------
Comprehensive income $ 10,248 $ 6,413
========= =========
<CAPTION>
Nine months ended
9/30/99 9/30/98
--------- ---------
<S> <C> <C>
Net income (loss) $ 28,420 $(17,981)
Other comprehensive (loss) income, net of tax:
Net unrealized (losses) gains on securities,
net of reclassification adjustment (4,802) 2,635
--------- ---------
Comprehensive income (loss) $ 23,618 $(15,346)
========= =========
</TABLE>
6. EARNINGS (LOSS) PER SHARE
Basic earnings per share ("EPS") is based on the weighted average number of
common shares outstanding during the period. Diluted EPS assumes the conversion
of dilutive convertible preferred stocks, dilutive convertible notes and the
exercise of dilutive options and warrants using the treasury stock method. Net
income is increased for interest expense on the convertible notes.
The following table summarizes the earnings and the average number of
common shares used in the calculation of basic and diluted EPS (in thousands,
except for per share amounts):
7
<PAGE> 10
<TABLE>
<CAPTION>
Quarter ended September 30, 1999
------------------------------------------
Net Income Shares Per share
(numerator) (Denominator) amount
------------------------------------------
<S> <C> <C> <C>
Basic EPS $10,970 59,102 $ 0.19
Effect of Dilutive Securities
Options and warrants 517
Convertible preferred stocks 1,717
Convertible notes 2,993
------------------------------------------
Diluted EPS 10,970 64,329 $ 0.17
==========================================
</TABLE>
<TABLE>
<CAPTION>
Quarter ended September 30, 1998
--------------------------------------
Net Income Shares Per share
(numerator) (Denominator) amount
--------------------------------------
<S> <C> <C> <C>
Basic EPS $5,068 58,785 $ 0.09
Effect of Dilutive Securities
Options and warrants 114
--------------------------------------
Diluted EPS $5,068 58,899 $ 0.09
======================================
</TABLE>
<TABLE>
<CAPTION>
Nine months ended September 30, 1999
-----------------------------------------
Net Income Shares Per share
(numerator) (Denominator) amount
-----------------------------------------
<S> <C> <C> <C>
Basic EPS $28,420 58,972 $ 0.48
Effect of Dilutive Securities
Options and warrants 663
Convertible preferred stocks 605
Convertible notes 4,035
Interest on convertible notes 848
-----------------------------------------
Diluted EPS $29,268 64,275 $ 0.46
=========================================
</TABLE>
<TABLE>
<CAPTION>
Nine months ended September 30, 1998
--------------------------------------------
Net Loss Shares Per share
(Numerator) (Denominator) amount
--------------------------------------------
<S> <C> <C> <C>
Basic EPS $(17,981) 50,242 $ (0 .36)
</TABLE>
7. SEGMENT REPORTING
Statement of Financial Accounting Standards No. 131 ("SFAS 131"),
"Disclosures about Segments of an Enterprise and Related Information", requires
that a public business enterprise report financial and descriptive information
about its reportable operating segments. Operating segments are components of an
enterprise about which separate financial information is
8
<PAGE> 11
available that is evaluated regularly by the chief operating decision maker in
deciding how to allocate resources and in assessing performance. SFAS 131 also
requires that all public business enterprises report information about the
revenues derived from the enterprise's products or services (or groups of
similar products and services), about the countries in which the enterprise
earns revenues and holds assets and about major customers regardless of whether
that information is used in making operating decisions.
The Company has two reportable segments: commercial products and government
products. The products are provided to a cross section of employer groups and
individuals through the Company's health plans in the Midwest, Mid-Atlantic, and
Southeastern United States. Commercial products include Health Maintenance
Organization (HMO), PPO, and Point-of-Service (POS) products. HMO products
provide comprehensive health care benefits to members through a primary care
physician. PPO and POS products permit members to participate in managed care
but allow them the flexibility to utilize out-of-network providers in exchange
for increased out-of-pocket costs.
Government products include Medicare Risk, Medicare Cost, and Medicaid. The
Company provides comprehensive health benefits to members participating in
government programs and receives premium payments from federal and state
governments. The Company evaluates the performance of its operating segments and
allocates resources based on gross margin. Assets are not allocated to specific
products and, accordingly, cannot be reported by segment.
<TABLE>
<CAPTION>
For the Quarter Ended September 30, 1999
(in thousands)
----------------------------------------
Government
Commercial Programs Total
----------------------------------------
<S> <C> <C> <C>
Revenues $370,845 $138,970 $509,815
Gross Margin 52,983 19,158 72,141
</TABLE>
<TABLE>
<CAPTION>
For the Quarter Ended September 30, 1998
(in thousands)
-----------------------------------------
Government
Commercial Programs Total
-----------------------------------------
<S> <C> <C> <C>
Revenues $441,460 $126,820 $568,280
Gross Margin 50,123 12,639 62,762
</TABLE>
<TABLE>
<CAPTION>
For the nine months ended September 30, 1999
(in thousands)
---------------------------------------------
Government
Commercial Programs Total
---------------------------------------------
<S> <C> <C> <C>
Revenues $1,136,373 $ 392,715 $1,529,088
Gross Margin 172,519 45,765 218,284
</TABLE>
9
<PAGE> 12
<TABLE>
<CAPTION>
For the nine months ended September 30, 1998
(in thousands)
------------------------------------------------
Government
Commercial Programs Total
------------------------------------------------
<S> <C> <C> <C>
Revenues $1,113,649 $ 340,373 $1,454,022
Gross Margin 101,571 35,634 137,205
</TABLE>
Following are reconciliations of reportable segment information to
financial statement amounts (in thousands):
<TABLE>
<CAPTION>
For the Quarter Ended September
30,
---------------------------------------
1999 1998
---------------------------------------
<S> <C> <C>
Revenues
Reportable Segments $ 509,815 $ 568,280
Other 20,074 24,998
------------------ -----------------
Total Revenues $ 529,889 $ 593,278
================== =================
Earnings Before Income Taxes
Gross margin from reportable segments $ 72,141 $ 62,762
Other revenues 20,074 24,998
Sellings, general and administrative (73,790) (78,077)
Depreciation and amortization (7,034) (7,504)
Other income 7,838 8,389
Interest expense (33) (2,580)
------------------ -----------------
Total Earnings Before Income Taxes $ 19,196 $ 7,988
================== =================
</TABLE>
10
<PAGE> 13
<TABLE>
<CAPTION>
For the Nine Months Ended
September 30,
---------------------------------------
1999 1998
---------------------------------------
<S> <C> <C>
Revenues
Reportable Segments $ 1,529,088 $ 1,454,022
Other 60,479 53,269
--------------------- ----------------
Total Revenues $ 1,589,567 $ 1,507,291
===================== ================
Earnings (Loss) Before Income Taxes
Gross margin from reportable segments $ 218,284 $ 137,205
Other revenues 60,479 53,269
Sellings, general and administrative (227,962) (206,434)
Depreciation and amortization (21,079) (18,141)
Merger costs -- (7,780)
Other income 22,310 19,513
Interest expense (1,732) (6,400)
--------------------- ----------------
Total Earnings (Loss) Before Income Taxes $ 50,300 $ (28,768)
===================== ================
</TABLE>
8. AHERF CHARGE
The Company and certain affiliated hospitals of Allegheny Health, Education
and Research Foundation (AHERF) have been involved in litigation to determine if
the Company had the financial responsibility for medical services provided to
the Company's members by the hospitals as a consequence of the bankruptcy filed
by AHERF. As a result of the bankruptcy, AHERF failed to pay for medical
services under its global capitation agreement with the Company covering
approximately 250,000 Company members in the western Pennsylvania market.
AHERF filed for bankruptcy protection on July 21, 1998, and shortly
thereafter the Company filed a lawsuit against the hospitals seeking a
declaratory judgment that the Company was not obligated to pay in excess of
$21.5 million to the hospitals for medical services provided by them to the
Company's members. The lawsuit also included additional claims for monetary
damages. In response, the hospitals filed a counterclaim alleging that the
Company's subsidiary, HealthAmerica Pennsylvania, Inc., was liable to the
hospitals for payment of these medical services.
As a result, the Company, which is ultimately responsible for these medical
costs, notwithstanding the global capitation agreement, recorded a charge of
$55.0 million in the second quarter of 1998 to establish a reserve for the
medical costs incurred by its members under the AHERF global capitation
agreement at the time of the bankruptcy filing. Although AHERF had not formally
rejected the capitation agreement, the parties were no longer operating under
its terms.
On July 22, 1999, the Company reached a settlement with the hospitals,
including Allegheny General Hospital (AGH), formerly owned by AHERF, and its new
owner, Western Pennsylvania Health Care System (West Penn), whereby the
hospitals agreed that the Company would not be liable for the payment of the
medical services rendered by the hospitals to the Company's members prior to
July 21, 1998, the date of AHERF's bankruptcy filing. Simultaneous with the
settlement, the Company signed a new three-year provider contract with West
Penn. The conditions to execute the settlement and the provider contract were
finalized in October 1999 and, as a result, all liability issues surrounding
AHERF's failure to fulfill its contractual obligations and Coventry's remaining
obligations have been determined and all AHERF-related litigation has been
concluded.
As of September 30, 1999, approximately $35.4 million of the $55.0 million
reserve had been paid for medical claims. As a result of the settlement,
Coventry expects to release $6.3 million of the reserve, which will be reflected
as a gain in the fourth quarter and year-end 1999 results. The balance of the
reserve represents Coventry's remaining obligations under the settlement and
will be expended through August 2007.
11
<PAGE> 14
9. MERGER COSTS
In connection with the acquisition of the PHC health plans, the Company
relocated its corporate headquarters from Nashville, Tennessee to Bethesda,
Maryland. As a result, the Company established a one-time reserve in 1998 of
approximately $7.8 million for the incurred and anticipated costs related to
the relocation of the corporate office and other direct merger related costs.
The reserve is primarily comprised of severance costs related to involuntary
terminations, relocation costs for management personnel, and lease costs, net
of sublease income, related to the unused space remaining at the old
headquarters location. The anticipated merger costs were less than the original
reserve established, resulting in a credit to earnings of $1.3 million in the
fourth quarter of 1998. As of September 30, 1999, the Company expended
approximately $5.9 million and expects to make payments through December 2002
related to these charges.
10. LEGAL PROCEEDINGS
Group Health Plan, Inc. ("GHP"), a health plan subsidiary of the Company,
entered into an agreement, effective January 1, 1998, with Unity Health Network,
L.L.C. ("Unity") for Unity's provider network to provide health care services to
GHP's members in the southern and western areas of St. Louis County, Missouri.
The agreement contained risk sharing provisions. Disputes have arisen under the
agreement, cross-claims have been made and the matter has been submitted to
arbitration before the American Arbitration Association. GHP is demanding
payment from Unity of $7.6 million and specific performance under the agreement.
Unity is demanding payment from GHP of $14.5 million, specific performance of
certain provisions of the agreement and suspension of its payment obligations.
The Company believes that GHP has fulfilled all of its obligations under the
agreement, that the amount demanded by GHP is properly due to GHP, and that GHP
does not owe Unity the amounts claimed by Unity. The parties are currently
involved in arbitration proceedings. The Company intends to vigorously pursue
this matter, and expects to have a decision prior to December 31, 1999.
In the normal course of business, the Company has been named as a defendant
in various legal actions seeking payments for claims denied by the Company,
medical malpractice, and other monetary damages. The claims are in various
stages of proceedings and some may ultimately be brought to trial. Incidents
occurring through September 30, 1999 may result in the assertion of additional
claims. With respect to medical malpractice, the Company carries
12
<PAGE> 15
professional malpractice and general liability insurance for each of its
operations on a claims made basis with varying deductibles for which the Company
maintains reserves. In the opinion of management, the outcome of these actions
will not have a material adverse effect on the financial position or results of
operations of the Company.
The Company's industry is heavily regulated and the laws and rules
governing the industry and interpretations of those laws and rules are subject
to frequent change. Existing or future laws could have significant impact on the
Company's operations.
11. SUBSEQUENT EVENTS
On October 1, 1999, the Company acquired Carelink Health Plans
("Carelink"), the managed care subsidiary of Camcare, an integrated delivery
system. Carelink, based in Charleston, West Virginia, has approximately 43,000
commercial HMO and POS members, 12,000 Medicaid members and 1,500 enrollees from
self-insured employers, with annual premium revenue of approximately $93.0
million. Carelink's service area is generally contiguous with the West Virginia
counties currently served by the Company's health plans in West Virginia and
Virginia. The transaction was accounted for as a purchase in which the Company
paid approximately $8.0 million in cash in exchange for all of Carelink's stock.
Carelink is a wholly-owned subsidiary of Coventry, and will continue to use the
Carelink name in its service area. As part of the agreement, Carelink entered
into a 5-year provider contract with Camcare for health care services and a
3-year exclusive contract to continue providing health benefit coverage to
Camcare's employees and their dependents.
On November 1, 1999, the Company's subsidiary, Principal Health Care of the
Carolinas, Inc., acquired Kaiser Foundation Health Plan of North Carolina's
commercial membership in Charlotte, North Carolina for approximately $150 per
member. Kaiser's Charlotte operation currently has approximately 31,000 HMO and
POS members and generates approximately $53.0 million in annual premium revenue.
On November 5, 1999, the Company announced that it intends to close its
subsidiary, Principal Health Care of Indiana, Inc., by the end of the second
quarter 2000, pending regulatory approval. The health plan currently has
approximately 26 employees and 24,000 members throughout the state. As a result
of the costs associated with exiting the Indiana market, the Company expects to
take a $2.0 million charge in the fourth quarter of 1999.
On November 12, 1999, Coventry announced that it had signed a definitive
agreement with The Anthem Companies, Inc. to acquire Anthem's West Virginia
managed care subsidiary, PrimeONE, Inc. PrimeONE has approximately 18,000
commercial members and annual premium revenue of $32 million. PrimeONE's service
area covers the entire state of West Virginia, expanding Coventry's existing
West Virginia service area into the north-eastern section of the state. The
acquisition will bring Coventry's total membership in West Virginia to over
109,000 and is expected to close in the first quarter of 2000, subject to
regulatory and other customary approvals and minimum membership criteria.
13
<PAGE> 16
ITEM 2:
MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Quarter and nine months ended September 30, 1999 and 1998
GENERAL
Overview
Coventry Health Care, Inc. ("Coventry"), successor-in-interest to Coventry
Corporation, is a managed health care company that provides comprehensive health
benefits and services to a broad cross-section of employer and government-funded
groups in the Midwest, Mid-Atlantic and Southeastern United States.
As of September 30, 1999, Coventry had 1,125,699 members for whom it
assumes underwriting risk ("risk members") and 238,304 members of self-insured
employers for whom it provides management services but does not assume
underwriting risk ("non-risk members"). The following tables show the total
number of members in continuing operations as of September 30, 1999 and 1998 and
the percentage change in membership between those dates, where applicable.
14
<PAGE> 17
COVENTRY HEALTH CARE, INC.
MEMBERSHIP
<TABLE>
<CAPTION>
September 30, %
1999 1998 Change
----------- ----------- -----------
<S> <C> <C> <C>
Membership by Market:
At-risk membership in continuing
operations:
Pennsylvania 391,639 425,684 (8.0%)
St. Louis 311,893 315,516 (1.1%)
Iowa 76,703 80,516 (4.7%)
Kansas City 64,148 46,496 38.0%
Delaware 57,048 53,948 5.7%
Richmond 52,302 54,596 (4.2%)
Wichita 39,976 33,839 18.1%
Louisiana 36,267 38,881 (6.7%)
Nebraska 26,686 33,825 (21.1%)
Georgia 26,314 17,763 48.1%
Indiana 23,584 27,275 (13.5%)
Carolina 19,139 21,530 (11.1%)
----------- ----------- -----------
Total at-risk membership 1,125,699 1,149,869 (2.1%)
Self-funded membership 238,304 220,332 8.2%
----------- ----------- -----------
Total membership in continuing
operations: 1,364,003 1,370,201 (0.5%)
=========== =========== ===========
Membership by Product:
At-risk membership in continuing
operations:
Commercial 933,348 987,390 (5.5%)
Medicare risk 66,791 60,979 9.5%
Medicare cost 702 1,954 (64.1%)
Medicaid 124,858 99,546 25.4%
----------- ----------- -----------
Total at-risk membership 1,125,699 1,149,869 (2.1%)
Self-funded membership 238,304 220,332 8.2%
----------- ----------- -----------
Total membership in continuing
operations 1,364,003 1,370,201 (0.5%)
=========== =========== ===========
</TABLE>
Coventry's operating expenses are primarily medical costs, including
medical claims under contractual relationships with a wide variety of providers,
and capitation payments. Medical claims expense also includes an estimate of
claims incurred but not reported ("IBNR"). Coventry currently believes that the
estimates for IBNR liabilities are adequate to satisfy its ultimate medical
claims liability after all medical claims have been reported. In determining the
Company's IBNR liabilities, Coventry employs
15
<PAGE> 18
plan by plan standard actuarial reserve methods (specific to the plan's
membership, product characteristics, geographic territories and provider
network) that consider utilization frequency and unit costs of inpatient,
outpatient, pharmacy and other medical costs, as well as claim payment backlogs
and the timing of provider reimbursements. Reserve estimates are reviewed by
underwriting, finance and accounting, and other appropriate plan and corporate
personnel and judgments are then made as to the necessity for reserves in
addition to the estimated amounts. Changes in assumptions for medical costs
caused by changes in actual experience, changes in the delivery system, changes
in pricing due to ancillary capitation and fluctuations in the claims backlog
could cause these estimates to change in the near term. Coventry periodically
monitors and reviews its IBNR reserves, and as actual settlements are made or
accruals adjusted, reflects these differences in current operations.
Acquisitions and Dispositions
Effective April 1, 1998, Coventry completed its acquisition of certain
health plans of Principal Health Care, Inc. ("PHC") from Principal Mutual Life
Insurance Company, now known as Principal Life Insurance Company, ("Principal
Life") for a total purchase price of approximately $330.2 million including
transaction costs of approximately $5.7 million. The acquisition was accounted
for using the purchase method of accounting and, accordingly, the operating
results of PHC have been included in Coventry's consolidated financial
statements since the date of acquisition. The purchase price consisted of
25,043,704 shares of Coventry's common stock at an assigned value of $11.96 per
share. In addition, a warrant valued at $25.0 million ("the Warrant") was issued
that grants Principal Life the right to acquire additional shares of Coventry's
common stock in the event that its ownership percentage of such common stock is
diluted below 40%. The Warrant is included as a component of additional paid-in
capital in the accompanying consolidated financial statements. Through April
2003, Principal Life is restricted from buying additional shares of Coventry's
common stock to increase its ownership percentage above 40%.
Coincident with the closing of the transaction, Coventry entered into a
Renewal Rights Agreement and a Coinsurance Agreement with Principal Life,
whereby it manages certain of Principal Life's indemnity health insurance
policies in the markets where Coventry does business and, on December 31, 1999,
would offer to renew such policies in force at that time. Effective June 1,
1999, Coventry amended these agreements with Principal Life and waived its
rights to reinsure and renew Principal Life's health insurance indemnity
business located in Coventry's service area. Coventry received $19.8 million in
cash in exchange for waiving these rights. At the date of the amendment, the
Renewal Rights and Coinsurance Agreements had a net book value of $19.7 million
resulting in an after tax gain of $0.1 million.
At the closing, Coventry also entered into a Marketing Services Agreement
and a Management Services Agreement with Principal Life. Both agreements extend
through December 31, 1999. Pursuant to the agreements, Coventry recognized
revenue of approximately $6.5 million for the three months ended September 30,
1999, and $19.0 million for the nine months ended September 30, 1999, and
expects to receive payments of approximately $25.4 million during the year
ended December 31, 1999, inclusive of the $19.0 million.
As a result of the acquisition, Coventry assumed an agreement with
Principal Life, whereby Principal Life pays a fee for access to Coventry's
16
<PAGE> 19
preferred provider organization ("PPO") network based on a fixed rate per
employee entitled to access the PPO network and a percentage of savings realized
by Principal Life. Under this agreement, Coventry recognized revenue of
approximately $2.0 million for the three months ended September 30, 1999 and
$6.0 million for the nine months ended September 30, 1999. The maximum amount
that can be paid under the percentage of savings component of the agreement is
$8.0 million for 1999.
On December 31, 1999, the Marketing Services Agreement, Management Services
Agreement, and PPO access agreement with Principal Life will expire and
Coventry will no longer receive revenue under these agreements. In anticipation
of the loss of these fees, Coventry is reducing selling, general and
administrative ("SG&A") costs through cost savings from service center
consolidation, headcount reductions and across-the-board reductions in
administrative expenses. In addition to SG&A reductions, Coventry plans to
implement rating improvements in two specific large groups, to improve margins
in the central Pennsylvania Medicare market, to improve margins in the St.
Louis Medicare market, and to increase gross margin through acquisitions,
including the recently completed acquisitions in Charlotte and West Virginia.
Effective November 30, 1998, Coventry sold its subsidiary, Principal Health
Care of Illinois, Inc., for $4.3 million in cash. The Illinois health plan
accounted for approximately 56,000 risk members and approximately 2,400 non-risk
members as of November 30, 1998.
On December 31, 1998, Coventry sold its subsidiary, Principal Health Care
of Florida, Inc., for $95.0 million in cash. The Florida health plan accounted
for approximately 156,000 risk members and approximately 5,500 non-risk members
as of December 31, 1998.
The proceeds from both sales were used to retire Coventry's credit
facility, to assist in improving the capital position of its regulated
subsidiaries, and for other general corporate purposes. Given the short time
period between the respective acquisition and sale dates and the lack of events
or other evidence which would indicate differing values, no gain or loss was
recognized on the sales of the Florida and Illinois health plans, as the sale
prices were considered by management to be equivalent to the fair values
allocable to these plans at the date of their acquisition from Principal Life
in April 1998.
In connection with the acquisition of certain PHC health plans and the
sales of the Florida and Illinois plans, Coventry established reserves of
approximately $33.0 million for the estimated transition costs of the PHC
health plans. These reserves are primarily comprised of severance costs related
to involuntary terminations of former PHC employees, relocation costs of former
PHC personnel, lease termination costs and contract termination costs. Through
September 30, 1999, Coventry has expended approximately $28.0 million related
to these reserves and expects to make payments on the remaining reserves
through July 2002.
In connection with the acquisition of PHC health plans, the Company
relocated its corporate headquarters from Nashville, Tennessee to Bethesda,
Maryland. As a result, the Company established a one-time reserve in 1998 of
approximately $7.8 million for the incurred and anticipated costs related to
the relocation of the corporate office and other direct merger related costs.
17
<PAGE> 20
The reserve is primarily comprised of severance costs related to
involuntary terminations, relocation costs for management personnel, and lease
costs, net of sublease income, related to the unused space remaining at the old
headquarters location. The anticipated merger costs were less than the original
reserve established, resulting in a credit to earnings of $1.3 million in the
fourth quarter of 1998. As of September 30, 1999, the Company expended
approximately $5.9 million and expects to make payments through December 2002
related to these charges.
Effective October 1, 1999, Coventry completed the transaction with Camcare,
an integrated delivery system, to acquire its managed care subsidiary, Carelink
Health Plans ("Carelink"). Carelink, based in Charleston, West Virginia, has
approximately 43,000 commercial HMO and POS members, 12,000 Medicaid members and
1,500 enrollees from self-insured employers with annual premium revenue of
approximately $93.0 million. Carelink's service area is generally contiguous
with the West Virginia counties currently served by Coventry's health plans in
West Virginia and Virginia. The transaction was accounted for as a purchase in
which the Company paid approximately $8.0 million in cash (subject to final
membership verification) in exchange for all of Carelink's stock. Carelink is a
wholly-owned subsidiary of Coventry, and will continue to use the Carelink name
in its service area. As part of the agreement, Carelink entered into a 5-year
provider contract with Camcare for health care services and a 3-year exclusive
contract to continue providing health benefit coverage to Camcare's employees
and their dependents.
On November 1, 1999, Coventry's subsidiary, Principal Health Care of the
Carolinas, Inc., acquired Kaiser Foundation Health Plan of North Carolina's
commercial membership in Charlotte, North Carolina for approximately $150 per
member. Kaiser's Charlotte operation currently has approximately 31,000 HMO and
POS members and generates approximately $53.0 million in annual premium revenue.
Coventry believes the acquisition will improve its North Carolina health plan's
financial position and allow the plan to capitalize on the growth potential in
the Charlotte market.
On November 5, 1999, Coventry announced that it intends to close its
subsidiary, Principal Health Care of Indiana, Inc., by the end of the second
quarter 2000, pending regulatory approval. The health plan currently has
approximately 26 employees and 24,000 members throughout the state. As a
result of the cost associated with exiting the Indiana market, Coventry expects
to take a $2.0 million charge in the fourth quarter of 1999.
The Indiana health plan was not operating profitably or demonstrating good
prospects for future growth. Although closing the plan will not have a
substantial impact on consolidated earnings, it will allow Coventry to focus
resources and management attention on its other markets. Coventry's transition
plan gives employers and members ample time to obtain coverage through one of
the many other companies operating in Indiana, and the Company will work with
employers to make the transition process as smooth as possible.
On November 12, 1999, Coventry announced that it had signed a definitive
agreement with The Anthem Companies, Inc. to acquire Anthem's West Virginia
managed care subsidiary, PrimeONE, Inc. PrimeONE has approximately 18,000
commercial members and annual premium revenue of $32 million. PrimeONE's service
area covers the entire state of West Virginia, expanding Coventry's existing
West Virginia service area into the north-eastern section of the state. The
acquisition will bring Coventry's total membership in West Virginia to over
109,000 and is expected to close in the first quarter of 2000, subject to
regulatory and other customary approvals and minimum membership criteria. The
Company plans to merge PrimeONE, based in Charleston, West Virginia, with its
existing Carelink operations, also based in Charleston, immediately following
the acquisition. The acquisition of PrimeONE continues Coventry's efforts to
build market share in existing and contiguous service areas through strategic,
financially attractive acquisitions. This transaction expands our West Virginia
service area statewide and increases our size in a market where we already built
market share earlier this year through the acquisition of Carelink Health Plans.
Legal Proceedings
The Company and certain affiliated hospitals of Allegheny Health, Education
and Research Foundation (AHERF) have been involved in litigation to determine if
the Company had the financial responsibility for medical services provided to
the Company's members by the hospitals as a consequence of the bankruptcy filed
by AHERF. As a result of the bankruptcy, AHERF failed to pay for medical
services under its global capitation agreement with the Company covering
approximately 250,000 Company members in the western Pennsylvania market. AHERF
filed for bankruptcy protection on July 21, 1998, and shortly thereafter the
Company filed a lawsuit against the hospitals seeking a declaratory judgment
that the Company was not obligated to pay in excess of $21.5 million to the
hospitals for medical services provided by them to the Company's members. The
lawsuit also included additional claims for monetary damages. In response, the
hospitals filed a counterclaim alleging that the Company's subsidiary,
HealthAmerica Pennsylvania, Inc., was liable to the hospitals for payment of
these medical services. As a result, the Company, which is ultimately
responsible for these medical costs, notwithstanding the global capitation
agreement, recorded a charge of $55.0 million in the second quarter of 1998 to
establish a reserve for the medical costs incurred by its members under the
AHERF global capitation agreement at the time of the bankruptcy filing. Although
AHERF had not formally rejected the capitation agreement, the parties were no
longer operating under its terms. On July 22, 1999, the Company reached a
settlement with the hospitals, including Allegheny General Hospital (AGH),
formerly owned by AHERF, and its new owner, Western Pennsylvania Health Care
System (West Penn), whereby the hospitals agreed that the Company would not be
liable for the payment of the medical services rendered by the hospitals to the
Company's members prior to July 21, 1998, the date of AHERF's bankruptcy filing.
Simultaneous with the settlement, the Company signed a new three-year provider
contract with West Penn. The conditions to execute the settlement and the
provider contract were finalized in October 1999 and, as a result, all liability
issues surrounding AHERF's failure to fulfill its contractual obligations and
Coventry's remaining obligations have been determined and all AHERF-related
litigation has been concluded. As of September 30, 1999, approximately $35.4
million of the $55.0 million reserve had been paid for medical claims. As a
result of the settlement, Coventry expects to release $6.3 million of the
reserve, which will be reflected as a gain in the fourth quarter and year-end
1999 results. The balance of the reserve represents Coventry's remaining
obligations under the settlement and will be expended through August 2007.
18
<PAGE> 21
Group Health Plan, Inc. ("GHP"), a health plan subsidiary of the Company,
entered into an agreement effective January 1, 1998 with Unity Health Network,
L.L.C. ("Unity") for Unity's provider network to provide health care services to
GHP's members in the southern and western areas of St. Louis County, Missouri.
The agreement contained risk sharing provisions. Disputes have arisen under the
agreement, cross-claims have been made and the matter has been submitted to
arbitration before the American Arbitration Association. GHP is demanding
payment from Unity of $7.6 million and specific performance under the agreement.
Unity is demanding payment from GHP of $14.5 million, specific performance of
certain provisions of the agreement and suspension of its payment obligations.
The Company believes that GHP has fulfilled all of its obligations under the
agreement, that the amount demanded by GHP is properly due to GHP, and that GHP
does not owe Unity the amounts claimed by Unity. The parties are currently
involved in arbitration proceedings. The Company intends to vigorously pursue
this matter, and expects to have a decision prior to December 31, 1999.
Other
As of December 31, 1998, Coventry exited the Medicare program in several
counties representing approximately 18,000 members. Approximately 10,000 of
those members were in the Florida and Illinois health plans that were sold
effective December and November 1998, respectively. The remaining markets were
exited because the reimbursement rates were not adequate and/or Coventry was
not successful in renegotiating adequate reimbursement rates.
On July 13, 1999, Coventry announced a new program designed to provide
total health and lifestyle management to the Medicare population. The 5,000
member pilot, launched in the Pittsburgh area, will combine a system of improved
delivery of care with specialized life and medical interventions for seniors
with varying care needs.
19
<PAGE> 22
RESULTS OF OPERATIONS
QUARTERS ENDED SEPTEMBER 30, 1999 AND 1998
Managed care premiums decreased by $58.5 million, or 10.3%, from the prior
year third quarter. This decrease was primarily attributable to the reduction of
membership resulting from the sales of the Florida and Illinois health plans in
the fourth quarter of 1998. Exclusive of the Florida and Illinois operations,
managed care premiums increased by $25.9 million, or 5.4%, primarily due to the
increase in Medicare risk and Medicaid membership of 31,124, or 19.4%, in
continuing markets.
In addition to the increase in Medicare risk and Medicaid membership,
combined premium yields increased by an average of $11.10, or 7.8%, on a per
member per month ("PMPM") basis to $152.68 PMPM, attributable to rate
increases.
The Medicare risk and Medicaid programs continue to grow in existing
markets through recently expanded programs. The increase in Medicare risk and
Medicaid membership was offset by a decrease in commercial membership of 54,042,
or 5.5%. The decrease in commercial membership occurred primarily in the
Pennsylvania market and was attributable to the disruption caused by the AHERF
bankruptcy filing and the conversion of a large group from a commercial risk
product to a self-funded product. Membership also decreased in other markets due
to Coventry's efforts to adhere to a strict pricing discipline. Coventry will
continue to be diligent in its attempt to obtain adequate premium increases and
expects its commercial premium rates to increase in excess of 10% for renewals
in the fourth quarter of 1999.
Management services revenue decreased $4.9 million, or 19.7%, from the
prior year third quarter primarily due to the decrease in PPO revenue under
Coventry's Agreement with Principal Life.
Health benefits expense decreased $67.8 million, or 13.4%, from the prior
year third quarter. Excluding the Florida and Illinois operations, health
benefits expense increased $3.3 million, or 0.8%. Coventry's medical loss ratio
decreased significantly from 89.0% in the prior year's third quarter to 85.8% in
the current year's third quarter.
As previously discussed, in July 1998 AHERF (the global capitation provider
organization for Coventry members in western Pennsylvania) filed for bankruptcy
protection under Chapter 11. In addition to the charge for the reserve
established to provide for the estimated IBNR claims on behalf of the globally
capitated Coventry members at the date of the bankruptcy filing, the medical
loss ratio for such members was negatively affected compared to the percentage
of premium paid to AHERF under the global capitation agreement. In addition,
Coventry increased administrative staff for patient utilization and medical
management in western Pennsylvania.
20
<PAGE> 23
Coventry continues to focus on ways to control its medical costs, including
implementation of best practices to reduce inpatient days and improvement of the
overall quality and level of care. Coventry is also continuously monitoring and
renegotiating with its provider networks to improve reimbursement rates and
improve member access to providers.
Medical claim liability accruals are periodically monitored and reviewed
with differences for actual settlements from reserves reflected in current
operations. In addition to the procedures for determining reserves as discussed
above, Coventry reviews the actual payout of claims relating to prior period
accruals, which may take up to six months to fully develop. Medical costs are
affected by a variety of factors, including the severity and frequency of
claims, that are difficult to predict and may not be entirely within the
Coventry's control. Coventry continually refines its reserving practices to
incorporate new cost events and trends.
SG&A expense decreased $4.3 million, or 5.5%, from the prior year third
quarter, due primarily to the sale of Florida & Illinois health plans. SG&A
expense, as a percent of revenue, increased to 13.9% for the quarter ended
September 30, 1999, from 13.2% in the prior year third quarter. The prior year
third quarter was unusually low due to changes in estimates of certain accrued
amounts in that quarter. In an effort to control costs and improve customer
service, Coventry is in the process of transferring certain of its operating
activities (e.g., customer service, claims processing, billing and enrollment)
to regional service centers. All activities are expected to be fully
transferred by the end of the second quarter of 2000.
Depreciation and amortization decreased $0.5 million, or 6.3%, from the
prior year third quarter. This decrease was primarily attributable to the
reduction of intangible assets resulting from the sales of the Florida and
Illinois health plans and the sale of the Renewal Rights and Coinsurance
Agreements described above.
Other income, net of interest expense, increased by $2.0 million, or 34.4%,
from the prior year third quarter. On a same store basis, other income, net of
interest expense, increased $3.1 million, or 144.7%, primarily due to the
reduction of interest expense from the reduction of debt.
Earnings from operations increased to $11.4 million from $2.2 million in
the prior year third quarter attributable to the various factors described
above.
Coventry's net income was $11.0 million compared to net income of $5.1
million for the third quarter of 1998. Net income per share was $0.17 for the
third quarter of 1999 compared to net income per share of $0.09 in the prior
year third quarter. The weighted average common shares outstanding was
approximately 64,329,000 and 58,899,000 on a diluted basis, for the quarters
ended September 30, 1999 and 1998, respectively.
NINE MONTHS ENDED SEPTEMBER 30, 1999 AND 1998
Managed care premiums increased $75.1 million for the nine months ended
September 30, 1999, or 5.2%, from the corresponding period in 1998 primarily
attributable to the additional revenue associated with the acquisition of the
PHC health plans in April 1998. The increase was also due to the increase in
Medicare risk and Medicaid membership of 31,124, or 19.4%, in continuing
21
<PAGE> 24
markets. In addition to the increase in risk membership, premiums increased by
an average of $10.16, or 7.3%, on a defined above PMPM basis, to $149.90 PMPM,
attributable to rate increases coupled with changes in the overall product mix
due to the acquisition of the PHC health plans. The Medicare risk and Medicaid
programs continue to grow in existing markets through recently expanded
programs. The increase in Medicare risk and Medicaid membership was offset by a
decrease in commercial membership of 54,042, or 5.5%. The decrease in
commercial membership occurred primarily in the western Pennsylvania market,
attributable to the disruption caused by the AHERF bankruptcy filing and the
conversion of a large group from a commercial risk product to a self-funded
product. Membership also decreased in other markets due to Coventry's efforts
to adhere to strict pricing discipline. Coventry will continue to be diligent
in attempting to obtain adequate premium increases and expects its commercial
premium rates to increase in excess of 10% for renewals in the fourth quarter
of 1999.
Management services revenue increased $7.2 million for the nine months
ended September 30, 1999, or 13.5%, from the corresponding period in 1998
primarily attributable to the PHC Administrative Services Only ("ASO")
operations and the conversion of a large group from a commercial risk product to
a self-funded product. Management services and marketing services agreements
that were entered into coincident with the acquisition of the PHC health plans
accounted for approximately $3.6 million, or 50.0% of the increase.
Health benefits expense increased $49.0 million for the nine months ended
September 30, 1999, or 3.9%, from the corresponding period in 1998 due to the
additional expenses associated with the acquisition of the PHC health plans in
April 1998. Coventry's medical loss ratio decreased slightly to 85.7% from
86.8% in the prior year nine months due to premium rate increases which were a
result of Coventry's efforts to maintain strict pricing discipline.
SG&A expense increased $21.5 million, or 10.4%, from the corresponding
period in 1998. SG&A expense, as a percent of revenue, increased to 14.3% for
the nine months ended September 30, 1999, from 13.7% in the corresponding period
in the prior year primarily attributable to additional costs associated with the
PHC health plans. In an effort to control costs and improve customer service,
Coventry is in the process of transferring certain of its operating activities
(e.g., customer service, claims processing, billing and enrollment) to regional
service centers. All activities are expected to be fully transferred by the end
of the second quarter of 2000.
Depreciation and amortization increased $2.9 million, or 16.2%, compared to
the corresponding period in the prior year primarily as a result of the
additional amortization related to the intangibles recorded as part of the
acquisition of the PHC health plans in April 1998.
Other income, net of interest expense, increased $7.5 million, or 56.9%,
for the nine months ended September 30, 1999 from the corresponding period in
1998, primarily due to the reduction of interest expense from the reduction of
debt and increased investment income resulting from the increase in invested
assets subsequent to the acquisition of the PHC health plans.
Earnings from operations increased $71.6 million, or 171.0% from the
corresponding period in 1998. Excluding charges related to AHERF and the
relocation of the corporate office, operating earnings increased $8.8 million,
or 42.2%, attributable to the various factors described above.
22
<PAGE> 25
Coventry's net income was $28.4 million compared to a loss of $18.0 million
for the corresponding period ended September 30, 1998. Net income per share
was $0.46 for the nine months of 1999 compared to a net loss per share of $0.36
in the nine months of 1998. Excluding the AHERF charge and merger costs,
Coventry would have reported earnings per share of $0.40 in the corresponding
period in 1998. The weighted average common shares outstanding were
approximately 64,275,000 and 54,102,000 on a diluted basis for the nine months
ended September 30, 1999 and 1998, respectively.
LIQUIDITY AND CAPITAL RESOURCES
Coventry's total cash and investments, excluding deposits of $24.3 million
restricted under state regulations, decreased $76.5 million to $525.3 million at
September 30, 1999 from $601.8 million at December 31, 1998. The decrease is
primarily attributable to $66.8 million of cash used in operations for the nine
month period. A significant portion of the cash used in operations
(approximately $51.6 million) was used to pay the runout of medical claims
associated with Principal Health Care of Florida, Inc. and Principal Health Care
of Illinois, Inc., the two health plans that were sold effective December 31,
1998 and November 30, 1998, respectively. The reduction in cash and investments
was also attributable to the reduction of deferred revenue resulting from
changes in the timing of premium payments from the U.S. Health Care Financing
Administration for Medicare membership and Coventry's efforts to reduce medical
claims inventory in 1999.
Coventry's investment guidelines emphasize investment-grade fixed-income
instruments to provide short-term liquidity and minimize the risk to principal.
Coventry believes that as its long-term investments are available for sale, the
amount of such investments should be added to current assets when assessing its
working capital and liquidity; on such basis, current assets plus long-term
investments available for sale, less short-term liabilities, increased to $241.2
million at September 30, 1999 from $187.8 million at December 31, 1998.
Coventry's HMO and insurance company subsidiary are required by state
regulatory agencies to maintain minimum surplus balances, thereby limiting the
dividends Coventry may receive from these companies. Including statutory reserve
requirements, Coventry's regulated subsidiaries had surpluses in excess of
requirements of approximately $91.2 million and $93.4 million at September 30,
1999 and December 31, 1998, respectively. Not including statutory reserves,
Coventry had cash and investments of approximately $74.5 million and $96.8
million at September 30, 1999 and December 31, 1998, respectively. These funds
are available to pay intercompany balances to regulated subsidiaries and for
general corporate purposes. Coventry also has entered into agreements with
certain of its regulated subsidiaries to provide additional capital, if
necessary, to prevent the subsidiary's insolvency.
During the quarter ended June 30, 1997, Coventry entered into a securities
purchase agreement ("Warburg Agreement") with Warburg, Pincus Ventures, L.P.
("Warburg") and Franklin Capital Associates III, L.P. ("Franklin") for the
purchase of $40.0 million of Coventry's 8.3% Convertible Exchangeable Senior
Subordinated Notes ("Coventry Notes"), together with warrants to purchase 2.35
million shares of Coventry's common stock for $42.35 million. The original
amount of the Coventry Notes, $36.0 million held by Warburg and $4.0 million
held by Franklin, were convertible into 3.6 million shares and 0.4 million
shares of Coventry's common stock,
23
<PAGE> 26
respectively, and were exchangeable at Coventry's or Warburg's option for shares
of convertible preferred stock. During the second and third quarters of 1999,
Coventry converted all Coventry Notes held by Franklin and Warburg totaling
$47.1 million, including interest, into 4,709,545 shares of Series A convertible
preferred stock.
Projected capital investments in 1999 of approximately $15.0 million
consist primarily of computer hardware, software and related equipment costs
associated with the development and implementation of improved operational and
communications systems. Approximately $9.0 million, net has been expended during
the nine months ended September 30, 1999.
Coventry believes that cash flows generated from operations, cash on hand
and investments, and excess funds in certain of its regulated subsidiaries will
be sufficient to fund continuing operations through September 30, 2000.
IMPACT OF YEAR 2000
Coventry's business is significantly dependent on information systems
("IS"). Coventry has implemented a Year 2000 readiness program designed to
prevent material information system disruption associated with the millennium
date change. The program includes an inventory and review of all core
application systems, networks, desktop systems, infrastructure and critical
information supply chains. Coventry's Year 2000 readiness program can be broken
down into five categories: 1) IS hardware, software and networks, 2) office
equipment which relies on microchips or telecommunications, 3) buildings and
facilities, 4) business partners and customers, and 5) business risk and
contingency planning. As anticipated, the Year 2000 readiness program was
substantially completed by the second quarter of 1999. The total estimated cost
of the program is approximately $13.1 million, of which $12.2 million had been
incurred through September 30, 1999. No material impact on critical IS
development was caused by Year 2000 initiatives. The cost of Year 2000
modifications is based on management's best estimates. Actual costs, however,
may differ from those currently anticipated. All Year 2000 initiatives are
monitored by a steering committee made up of management personnel representing
Coventry's legal, compliance, finance, actuarial, medical and IS departments.
The steering committee reports the status of Coventry's Year 2000 readiness
program to senior management, who report to the board of directors.
While Coventry currently believes that its planning efforts and anticipated
modifications to existing systems and purchases of new systems will be adequate
to address its Year 2000 concerns, there can be no assurance that the systems of
other companies on which Coventry's systems and operations rely will be
converted on a timely basis and will not have a material adverse effect on
Coventry.
The specific phases of the Year 2000 readiness program are as follows:
IS Hardware, Software and Networks
Coventry has historically purchased its core software applications rather
than build them. Coventry is currently operating on two different platforms for
its core managed health care software applications. The former Coventry
Corporation health plans use the IDX managed care system. The current release of
that system is vendor certified to be Year 2000 compliant and Coventry has
converted its applications to that current release in a live
24
<PAGE> 27
production environment. All operating system upgrades on above-named systems
have been completed. Future Date Testing for these systems were completed as
scheduled. The former PHC health plans are using a different third party
product, which has been customized and is no longer supported by the vendor.
That system utilizes Julian dates for all internal processes and is Year 2000
compliant. As part of Coventry's readiness program, the entire application has
been reviewed, necessary changes identified and programming modifications have
been completed, tested and are in production. The computer operating systems are
tested and are in production.
All internally developed systems have been inventoried and plans made to
upgrade, modify or replace them as necessary to make them Year 2000 compliant.
All internally developed systems are in a Year 2000 ready state or are moving to
an inquiry only status. Coventry has requested all vendors of currently
installed software to disclose their products' current Year 2000 readiness and
their plan for achieving Year 2000 readiness. All vendor software code except
as noted is certified to be Year 2000 ready. All network and server hardware
and software systems have been tested and repaired and are now Year 2000 ready.
Other major purchased applications that were non-compliant have been
replaced by upgraded software from vendors or replaced by new purchased systems.
Those applications include replacements for Coventry's general ledger and
financial reporting applications, a data warehouse for financial and medical
information decision support, and a proposal and rating system to support the
underwriting and marketing processes. The general ledger, underwriting and data
warehouse systems are complete and in production. Non-critical financial and
human resource systems have also been completed.
Office Equipment
Coventry has requested its significant office equipment vendors to submit
Year 2000 readiness statements about their products. Coventry has received the
majority of such statements and is determining the extent to which nonconforming
office equipment should be upgraded or replaced. Second notices to
non-conforming or non-responding vendors have been issued.
Buildings and Facilities
All landlords and building management companies have been sent surveys with
respect to each key operating and security system in company locations. Second
surveys received have been evaluated to assess potential risks and no material
risks have been found.
Business Partners and Customers
Coventry has communicated with its key business associates, such as
financial institutions, third party vendors, provider and hospital networks,
contractors and service providers to ensure that those parties have appropriate
plans to remediate Year 2000 issues where their systems interface with
Coventry's systems or otherwise impact its operations. Coventry is assessing the
extent to which its operations are vulnerable should those organizations fail to
remediate properly their computer systems. However, Coventry has little or no
control over the efforts of those key business associates and other suppliers to
become Year 2000 compliant. Certain of the services provided by those parties,
particularly telecommunications providers, financial institutions and major
hospitals and medical care
25
<PAGE> 28
providers, could have a material adverse effect on Coventry's financial
condition and results of operations if these services or operations are not Year
2000 compliant.
Risk Assessment and Contingency Planning
Coventry is reviewing its existing contingency plans for necessary
modifications to address specific Year 2000 issues and Day 1 and Contingency
Plans have been created. As part of its contingency planning Coventry has
analyzed the most likely worst case scenario that could result from Year
2000-related failures. Coventry's best estimate of that scenario, based on
current information, would involve a combination of major operational
disruptions by its principal depository financial institutions, utility and
telecommunication suppliers and its largest hospital and provider networks in
its Pennsylvania and Missouri markets. Coventry's Year 2000 readiness program
and contingency planning efforts are designed to prevent and/or mitigate the
effects of such possible failures by evaluating technology risks and where
prudent, implementing contingency plans to deal with these risks.
LEGISLATION AND REGULATION
Numerous proposals have been introduced in the United States Congress and
various state legislatures relating to managed health care reform. Some
proposals, if enacted, could, among other things, limit Coventry's ability to
control medical costs, increase Coventry's exposure to liability to members for
coverage denials or delays, require certain coverages and impose other
requirements on managed care companies. Although the provisions of legislation
that may be adopted at the state level cannot be accurately and completely
predicted at this time, Coventry's management believes that the ultimate outcome
of currently proposed legislation and state legislation enacted to date should
not have a material adverse effect on its operations. On the federal level,
Coventry expects that some form of managed health care reform may be enacted. At
this time, it is unclear when such legislation might be enacted as well as the
content of any new provisions. Coventry's management believes that the ultimate
outcome of such federal legislation should not have a material adverse effect on
its operations.
RISK FACTORS
Coventry's business is subject to numerous risks and uncertainties which
may affect its results of operations in the future and may cause such future
results of operations to differ materially and adversely from projections
included in or underlying any forward-looking statements made by or on behalf of
the Company. Some specific risks that could affect Coventry include the
following:
IF COVENTRY IS UNABLE TO INCREASE ITS REVENUES, IT MAY NOT BE PROFITABLE AND THE
VALUE OF YOUR INVESTMENT MAY DECLINE.
Increases in Coventry's revenues will be generally dependent upon its
ability to increase premiums and membership. Premium rates for managed care
plans generally have increased in recent months, but Coventry could experience
unforeseen decreases or severely limited increases in future premium revenues.
Factors that could affect Coventry's ability to maintain or increase revenues
include (i) loss of membership to competitors, (ii) failure to attract new
members, (iii) inability to increase premiums due to regulatory restrictions,
(iv) loss of membership due to increased premium
26
<PAGE> 29
rates, (v) withdrawal from unprofitable markets, and (vi) consumer preferences
for lower priced health care options. Currently, the majority of Coventry's
premium revenues come from commercial employer contracts. Large customers, whose
contracts are generally renewable each year, represent a significant percentage
of the membership of one or more of Coventry's health plans and twenty percent
(20%) of Coventy's overall membership. The loss of one or more of these
customers could result in a material adverse effect with respect to future
revenues and Coventry's ability to cover costs. Also, 25.7% of Coventry's
premium revenues year-to-date were derived from governmental programs, including
Medicare and Medicaid. These premiums are generally fixed by the government and
Coventry cannot adjust them based on its anticipated costs. Recent legislation
has limited Medicare premium increases substantially as compared to increases
permitted in prior years. As a result, the future costs of Coventry's government
programs could exceed the future premium revenues received. Such losses of
premium revenues and membership could adversely affect Coventry's financial
position and profitability and cause a decline in the value of your investment
in Coventry.
LIMITATIONS ON COVENTRY'S ABILITY TO PROJECT ACTUAL HEALTH CARE COSTS COULD
RESULT IN COSTS BEING HIGHER THAN PREMIUM REVENUES, WHICH COULD ADVERSELY AFFECT
YOUR INVESTMENT IN COVENTRY.
Coventry expects to use a substantial portion of its revenues to pay the
costs of health care services and supplies delivered to its membership. The
total cost incurred by Coventry is affected by the number of individual services
rendered and the cost of each service. A large part of the Coventry's premium
revenue is set on an annual basis before the actual services are delivered and
the related costs are incurred. The number of individual services rendered and
the cost of each service affect Coventry's total health care costs. While the
Company attempts to base the premiums it charges, at least in part on its
estimate of expected health care costs over the fixed premium period, other
factors may limit its ability to fully base premiums on estimated costs and
could cause actual health care costs to exceed estimated health care costs.
These factors could include (i) the increased cost of individual health care
services, (ii) the type and number of individual health care services delivered
may exceed our expectations, (iii) the occurrence of catastrophes or epidemics,
(iv) seasonality and trends, (v) general inflation, (vi) new mandated benefits
or other regulatory changes that increase its costs, (vii) operational issues,
(viii) insured population characteristics, (ix) competitive pressures and (x)
other unforeseen occurrences. Coventry establishes reserves based on estimates
of the costs incurred for covered services received by members but not yet
reported. Coventry's reserves for incurred-but-not-reported liabilities may fall
short of the actual amount of incurred-but-not-reported liabilities. This
shortfall could significantly change Coventry's results of operations, affect
profitability and adversely affect the value of your investment in Coventry.
Historically, increases in the cost of health care services and higher than
expected use of health care services have caused health care costs to rise
faster than general inflation. While these increases have moderated recently,
Coventry cannot insure that the cost of health care services or utilization will
not again increase at a more rapid pace. Such increases could significantly
change results of operations, affect profitability and adversely affect the
value of your investment.
27
<PAGE> 30
FAILURE TO OBTAIN COST-EFFECTIVE AGREEMENTS WITH A SUFFICIENT NUMBER OF
PROVIDERS MAY RESULT IN HIGHER MEDICAL COSTS AND LOSS OF MEMBERSHIP, WHICH COULD
CAUSE YOUR INVESTMENT IN COVENTRY TO DECLINE IN VALUE.
Prior to 1997, Coventry's St. Louis and Pennsylvania health plans offered
members access to Coventry-owned and Coventry-staffed medical centers, as well
as to networks of contracting providers. During 1997, Coventry's medical centers
were sold to provider systems that have contracted to provide care to Coventry's
members continuing to use these centers. Coventry expects that substantially all
of its members will be served by providers contracting with the Company to
provide the requisite medical care. Coventry's ability to contract successfully
with a sufficiently large number of providers in a given geographic market will
affect the relative attractiveness of Coventry's managed care products in those
markets. The terms of those provider contracts also have a material impact on
Coventry's medical costs and its ability to control these costs. In some of
Coventry's markets, certain provider systems have a major presence. If these
provider systems refuse to contract with Coventry, place Coventry at a
competitive disadvantage or use their market position to negotiate contracts
unfavorable to Coventry, product offerings or profitability in these markets
could be adversely affected.
Among the medical cost control techniques Coventry has utilized are
capitation agreements with providers pursuant to which the providers are paid a
fixed dollar amount per member per month, with the provider obligated to provide
all of a particular type of medical service required by the members, and global
capitation agreements pursuant to which a single integrated hospital-physician
provider system provides substantially all hospital and medical services to a
large number of members for a fixed percentage of the premium we charge with
respect to those members. While these systems may shift to the contracting
provider system the risk that medical costs will exceed the amounts anticipated,
Coventry will be exposed to the risks that the provider systems are financially
unable or unwilling to fulfill their payment or medical care obligations under
the capitation agreements or that members may prefer other providers in the
market.
OPERATING RESULTS MAY NOT CONTINUE TO IMPROVE IN 1999 AND 2000, WHICH COULD
NEGATIVELY AFFECT COVENTRY'S EARNINGS AND THE VALUE OF YOUR INVESTMENT IN
COVENTRY MAY DECLINE.
Coventry's operating loss in 1998 was primarily attributable to charges
related to the establishment of reserves related to the bankruptcy of AHERF, and
to the relocation of its corporate headquarters. Although the Company has
reached a settlement with respect to the AHERF bankruptcy and Coventry's
operating results have improved, there can be no assurance that operating
results will continue to improve. If Coventry experiences operating losses in
1999 and 2000, its earnings will be negatively affected and the value of your
investment in Coventry may decline.
PRINCIPAL LIFE INSURANCE COMPANY AND ITS AFFILIATES MAY BE ABLE TO TAKE CONTROL
OF COVENTRY, WHICH COULD ADVERSELY AFFECT THE VALUE OF YOUR SHARE OF COVENTRY
COMMON STOCK
As a result of Coventry's acquisition of the Principal Health Care health
plans, Principal Life owns approximately 40% of Coventry's common
28
<PAGE> 31
stock, on a fully diluted basis. Although Principal Life has agreed to a
limitation on acquiring additional shares of Coventry's common stock, Principal
Life has the right to acquire additional shares of Coventry's common stock in
order to maintain ownership of up to 40% of Coventry's common stock, and has the
right to elect at least one member of Coventry's Board of Directors for each 6%
ownership of Coventry's common stock until April 2003. Prior to April 2003,
Principal Life has agreed to vote its shares in favor of an acquisition required
to be approved by shareholders that the Board has recommended and that has been
approved by a majority of shareholders other than Principal Life. After April
2003 or after a third party acquires more voting securities than those held by
Principal Life, there will be no restrictions on the acquisition of Coventry's
common stock by Principal Life. As a result, Principal Life, in addition to
having an effective veto over transactions involving a shareholder vote
(assuming it were to continue to beneficially own 40% of Coventry's common
stock), could acquire over 50% of Coventry's common stock and take actions
requiring a shareholder vote without the need for any vote of Coventry's
remaining shareholders. If Principal Life were to acquire over 50% of common
stock, it would have actual control of Coventry and would be the majority
shareholder and controlling vote in all actions involving a shareholder vote. As
the majority shareholder, Principal Life could block transactions that were
advantageous to the minority shareholders. There could be no assurance that the
value of your investment in Coventry would not decline because future investors
would not consider Coventry's common stock to be an attractive investment.
FORWARD-LOOKING STATEMENTS
The statements contained in this Form 10-Q that are not historical are
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are
subject to risks and uncertainties including the "Risk Factors" described
above and in Coventry's filings with the Securities and Exchange Commission.
These risks and uncertainties could cause actual operations and results to
differ materially from those expected, anticipated, or projected. Among the
factors that may materially affect Coventry's business are potential increases
in medical costs, difficulties in increasing premiums due to competitive
pressures, price restrictions under Medicaid and Medicare, imposition of
regulatory restrictions, issues relating to marketing of products or
accreditation or certification of the products by private or governmental
bodies, difficulties in obtaining or maintaining favorable contracts with health
care providers, credit risks on global capitation arrangements, financing
costs and contingencies and litigation risk. Coventry undertakes no obligation
to update the forward-looking information set forth herein as a result of new
information or future events.
29
<PAGE> 32
ITEM 3: Quantitative and Qualitative Disclosures of Market Risk
Coventry's only material risk in investments in financial instruments is in
its debt securities portfolio. Coventry invests primarily in marketable state
and municipal, U.S. Government and agencies, corporate, and mortgage-backed debt
securities. Coventry does not invest in financial instruments of a hedging or
derivative nature.
Coventry has established policies and procedures to manage its exposure to
changes in the fair value of its investments. These policies include emphasizing
credit quality, managing portfolio duration, maintaining or increasing
investment income through high coupon rates, and actively managing profile and
security mix depending upon market conditions. Coventry has classified all of
its investments as available-for-sale. The fair value of the Company's
investments in debt securities at September 30, 1999 was $364.2 million. Debt
securities at September 30, 1999 mature according to their contractual terms, as
follows (actual maturities may differ because of call or prepayment rights):
<TABLE>
<CAPTION>
Amortized Fair
Cost Value
----------------------
(in thousands)
<S> <C> <C>
Maturities:
Within 1 year $ 84,737 $ 84,742
1 to 5 years 102,054 101,733
6 to 10 years 67,203 65,407
Over 10 years 112,647 112,336
Other securities without stated maturity -- --
Total short-term and long-term ----------------------
Securities $366,641 $364,218
========= ========
</TABLE>
Coventry believes its investment portfolio is diversified and expects no
material loss to result from defaults. The mortgage-backed securities are
insured by GNMA and FNMA.
Coventry's projections of hypothetical net losses in fair value of its
interest rate sensitive instruments, should potential changes in interest rates
occur, are presented below. While Coventry believes that the potential interest
rate change is reasonably possible, actual results may differ.
Based on Coventry's debt securities portfolio and interest rates at
September 30, 1999, a 100 basis point increase in interest rates would result in
a decrease of $7.4 million, or 2.0%, in the fair value of the portfolio. Changes
in interest rates may affect the fair value of the debt securities portfolio and
may result in unrealized gains or losses. Gains or losses would be realized upon
the sale of the investments.
30
<PAGE> 33
PART II. OTHER INFORMATION
ITEM 1: Legal Proceedings
Settlement with AHERF related entities. The Company and certain affiliated
hospitals of Allegheny Health, Education and Research Foundation (AHERF) have
been involved in litigation to determine if the Company had the financial
responsibility for medical services provided to the Company's members by the
hospitals as a consequence of the bankruptcy filed by AHERF. As a result of the
bankruptcy, AHERF failed to pay for medical services under its global capitation
agreement with the Company covering approximately 250,000 Company members in the
western Pennsylvania market. AHERF filed for bankruptcy protection on July 21,
1998, and shortly thereafter the Company filed a lawsuit against the hospitals
seeking a declaratory judgment that the Company was not obligated to pay in
excess of $21.5 million to the hospitals for medical services provided by them
to the Company's members. The lawsuit also included additional claims for
monetary damages. In response, the hospitals filed a counterclaim alleging that
the Company's subsidiary, HealthAmerica Pennsylvania, Inc., was liable to the
hospitals for payment of these medical services. As a result, the Company, which
is ultimately responsible for these medical costs, notwithstanding the global
capitation agreement, recorded a charge of $55.0 million in the second quarter
of 1998 to establish a reserve for the medical costs incurred by its members
under the AHERF global capitation agreement at the time of the bankruptcy
filing. Although AHERF had not formally rejected the capitation agreement, the
parties were no longer operating under its terms. On July 22, 1999, the Company
reached a settlement with the hospitals, including Allegheny General Hospital
(AGH), formerly owned by AHERF, and its new owner, Western Pennsylvania Health
Care System (West Penn), whereby the hospitals agreed that the Company would not
be liable for the payment of the medical services rendered by the hospitals to
the Company's members prior to July 21, 1998, the date of AHERF's bankruptcy
filing. Simultaneous with the settlement, the Company signed a new three-year
provider contract with West Penn. The conditions to execute the settlement and
the provider contract were finalized in October 1999 and, as a result, all
liability issues surrounding AHERF's failure to fulfil its contractual
obligations and Coventry's remaining obligations have been determined and all
AHERF-related litigation has been concluded. As of September 30, 1999,
approximately $35.4 million of the $55.0 million reserve had been paid for
medical claims. As a result of the settlement, Coventry expects to release $6.3
million of the reserve, which will be reflected as a gain in the fourth quarter
and year-end 1999 results. The balance of the reserve represents Coventry's
remaining obligations under the settlement and will be expended through August
2007.
Unity Arbitration. Group Health Plan, Inc. ("GHP"), a health plan
subsidiary of the Company, entered into an agreement, effective January 1, 1998,
with Unity Health Network, L.L.C. ("Unity") for Unity's provider network to
provide health care services to GHP's members in the southern and western areas
of St. Louis County, Missouri. The agreement contained risk sharing provisions.
Disputes have arisen under the agreement, cross-claims have been made and the
matter has been submitted to arbitration before the American Arbitration
Association. GHP is demanding payment from Unity of $7.6 million and specific
performance under the agreement. Unity is demanding payment from GHP of $14.5
million, specific performance of certain provisions of the agreement and
suspension of its payment obligations. The Company believes that GHP has
fulfilled all of its obligations under the agreement, that the amount demanded
by GHP is properly due to GHP, and that GHP does not owe Unity the amounts
claimed by Unity. The parties are currently involved in arbitration proceedings.
The Company intends to vigorously pursue this matter, and expects to have a
decision prior to December 31, 1999.
Other Legal Actions. In the normal course of business, the Company has been
named as a defendant in various legal actions seeking payments for claims denied
by the Company, medical malpractice, and other monetary
31
<PAGE> 34
damages. The claims are in various stages of proceedings and some may ultimately
be brought to trial. Incidents occurring through September 30, 1999 may result
in the assertion of additional claims. With respect to medical malpractice, the
Company carries professional malpractice and general liability insurance for
each of its operations on a claims made basis with varying deductibles for which
the Company maintains reserves. In the opinion of management, the outcome of
these actions should not have a material adverse effect on the financial
position or results of operations of the Company.
Other managed care companies have been sued recently in class action
lawsuits claiming violations of the federal racketeering act (RICO) and federal
employee benefits law (ERISA), and generally claiming that managed care
companies overcharge consumers and misrepresent that they deliver quality
health care. Although it is possible that Coventry may be the target of a
similar suit, Coventry believes there is no valid basis for such a suit.
The Company's industry is heavily regulated and the laws and rules
governing the industry and interpretations of those laws and rules are subject
to frequent change. Existing or future laws could have significant impact on the
Company's operations.
ITEMS 2, 3, 4 and 5: Not Applicable
ITEM 6: Exhibits and Report on Form 8-K
(a) Exhibits required to be filed by Item 601 of Regulation S-K.
<TABLE>
<CAPTION>
Exhibit
No. Description of Exhibit
------- -----------------------
<S> <C>
10.1 Amendment to Employment Agreement dated July 12,
1999, between Thomas McDonough and Coventry Health
Care, Inc.
10.2 Common Stock Purchase Warrant issued as January 4,
1999 to John W. Campbell.
11.1 Computation of Net Earnings Per Share
27 Financial Data Schedule (for SEC use only)
</TABLE>
(b) Reports on Form 8-K
No reports on Form 8-K were filed during the quarter ended September
30, 1999.
32
<PAGE> 35
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this Report to be signed on
its behalf by the undersigned, thereunto duly authorized.
COVENTRY HEALTH CARE, INC.
(Registrant)
Date: November 15, 1999 By: /s/ Allen F. Wise
----------------- ---------------------------
Allen F. Wise
President, Chief Executive
Officer and Director
Date: November 15, 1999 By: /s/ Dale B. Wolf
----------------- ---------------------------
Dale B. Wolf
Executive Vice President,
Chief Financial Officer,
Treasurer and Principal
Accounting Officer
33
<PAGE> 1
AMENDMENT TO EMPLOYMENT AGREEMENT
This Amendment to Employment Agreement is entered into as of the 12th day
of July, 1999, by and between Thomas McDonough ("Executive") and Coventry Health
Care, Inc ("Employer"), a Delaware corporation with its principal place of
business at 6705 Rockledge Drive, Suite 900, Bethesda, MD 20817.
WITNESSETH:
WHEREAS, Executive and Employer are parties to an Employment Agreement
entered into as of the 13th day of March 1998 ("Employment Agreement") under
which, among other things, Executive became employed as Employer's Executive
Vice President commencing on April 1, 1998 (the "Date of Employment"); and
WHEREAS, the Employment Agreement contains a provision stating that
Executive shall be eligible to participate in a three-year long term incentive
compensation plan, the terms and conditions of which were to be mutually agreed
upon by Employer and Executive following the Date of Employment and included as
an amendment to the Employment Agreement; and
WHEREAS, Executive and Employer have reached agreement as to the terms
and conditions of said long term incentive compensation plan;
NOW THEREFORE, in consideration of the premises hereof and of the mutual
promises and agreements contained herein and in the Employment Agreement, the
parties hereto, intending to be legally bound, hereby agree to the following
Long Term Incentive Compensation Plan:
1. DEFINITIONS. For purposes of this Amendment to Employment Agreement:
A. The items defined in paragraph 25 of the Employment
Agreement have the same meaning herein as in the Employment
Agreement.
B. "Area of Performance" shall mean Risk Membership, General
and Administrative Expenses PMPM, Earnings Per Share, or
Medical Costs PMPM.
C. "Commercial Risk Medical Costs PMPM" shall mean the
Employer's medical costs per member per month for all
non-Medicare risk plans.
D. "Commercial Risk Membership" shall mean Employer's Risk
Membership associated with all non-Medicare risk plans.
E. "Earnings Per Share" shall mean the Employer's diluted
earnings per share, calculated according to the Employer's
normal accounting principles, after the exclusion of any
extraordinary items, to the extent such items are disclosed
in the Employer's regular financial statements. With
respect to the determination of the Base Line Performance
for 1998
<PAGE> 2
as set forth in paragraph 3, below, such extraordinary
charges specifically include the charge taken due to the
AHERF bankruptcy and the charge associated with the
Principal merger.
F. "General & Administrative Expenses PMPM" shall mean the
Employer's general and administrative expenses computed on
a per member per month basis, excluding charges for
depreciation and amortization of goodwill (and similar
intangible write-offs) calculated according to the
Employer's normal accounting principles. With respect to
the determination of the Base Line Performance for 1998 as
set forth in paragraph 3, below, all general and
administrative expenses directly attributable to the health
plans of PHC of Florida, Inc., and PHC of Illinois, Inc.
shall be excluded.
G. "Medical Costs PMPM" shall mean the Employer's medical
costs per member per month, calculated according to the
Employer's normal accounting principles.
H. "Medicare Risk Medical Costs PMPM" shall mean the
Employer's medical costs per member per month for Medicare
risk plans.
I. "Medicare Risk Membership" shall mean Employer's Risk
Membership associated with Medicare risk plans.
J. "PMPM" shall mean "per member per month."
K. "Risk Membership" shall mean the number of individuals
enrolled in a health plan for which Employer bears the
financial risk of medical costs. With respect to the
determination of the Base Line Performance for 1998 as set
forth in paragraph 3, below, it excludes all individuals
enrolled in the health plans of PHC of Florida, Inc., and
PHC of Illinois, Inc. With respect to the determination of
performance for the years 1999, 2000 and 2001, "Risk
Membership" shall exclude all individuals that were the
subject of acquisitions or sales on or after January 1,
1999.
L. "Sub-Area of Performance" shall mean Medicare Risk Medical
Costs PMPM or Commercial Risk Medical Costs PMPM.
2. AREAS OF PERFORMANCE. In addition to the compensation and benefits set
forth in the Employment Agreement, Executive may earn long term incentive
compensation based upon the Employer's actual performance in the following four
Areas of Performance: (1) Risk Membership; (2) General and Administrative
Expenses PMPM (3) Earnings Per Share; and (4) Medical Costs PMPM. The category
of Medical Costs PMPM shall be further divided into two Sub-Areas of
Performance: Medicare Risk Medical Costs PMPM and Commercial Risk Medical Costs
PMPM. In determining Executive's entitlement to long term incentive compensation
hereunder, each Area and Sub-Area of Performance will be assigned the following
weightings:
Page 2 of 9
<PAGE> 3
<TABLE>
<CAPTION>
AREA OF PERFORMANCE WEIGHTING
------------------- ---------
<S> <C>
Risk Membership 20 percent
General & Administrative PMPM 30 percent
Earnings Per Share 30 percent
Medical Costs PMPM 20 percent
Medicare Risk Medical Costs PMPM Medicare Risk Membership
divided by total Risk
Membership, as of December
31 of each year
Commercial Risk Medical Costs PMPM Commercial Risk Membership
divided by total Risk
Membership, as of December
31 of each year
</TABLE>
3. BASE LINE PERFORMANCE. The Employer's performance as of December 31,
1998 in each of the Areas and Sub-Areas of Performance shall constitute the Base
Line Performance for measuring the rate of change in subsequent years. It is
agreed that the Base Line Performance as of December 31, 1998 in each of the
Areas and Sub-Areas of Performance was as follows:
<TABLE>
<CAPTION>
AREA/SUB-AREA OF PERFORMANCE BASE LINE 12/31/98
---------------------------- ------------------
<S> <C>
Risk Membership 1,167,041
General & Administrative PMPM $ 18.72
Earnings Per Share $ 0.49
Medical Costs PMPM
Medicare Risk Medical Costs PMPM $403.79
Commercial Risk Medical Costs PMPM $108.46
</TABLE>
4. PERFORMANCE TARGETS. The parties have agreed to certain targeted
percentage rates of change in the Areas of Performance for the years 1999, 2000
and 2001, to be determined as at December 31, 1999, December 31, 2000 and
December 31, 2001, respectively.
<PAGE> 4
For 1999, the targeted percentage rates of change, based on the Base Line
Performance, are as follows:
<TABLE>
<CAPTION>
AREA/SUB-AREA OF PERFORMANCE PERFORMANCE TARGETS (1999)
---------------------------- --------------------------
<S> <C>
Risk Membership + 5 percent
General & Administrative PMPM - 6 percent
Earnings Per Share + 60 percent
Medical Costs PMPM
Medicare Risk Medical Costs PMPM No more than + 5 percent
Commercial Risk Medical Costs PMPM No more than + 3 percent
</TABLE>
For 2000, the targeted percentage rates of change are as follows:
<TABLE>
<CAPTION>
AREA/SUB-AREA OF PERFORMANCE PERFORMANCE TARGETS (2000)
---------------------------- --------------------------
<S> <C>
Risk Membership + 10 percent
General & Administrative PMPM - 6 percent
Earnings Per Share + 25 percent
Medical Costs PMPM
Medicare Risk Medical Costs PMPM No more than + 6 percent
Commercial Risk Medical Costs PMPM No more than + 4 percent
</TABLE>
For 2001, the targeted percentage rates of change are as follows:
<TABLE>
<CAPTION>
AREA/SUB-AREA OF PERFORMANCE PERFORMANCE TARGETS (2001)
---------------------------- --------------------------
<S> <C>
Risk Membership + 10 percent
General & Administrative PMPM - 5 percent
Earnings Per Share + 20 percent
Medical Costs PMPM
Medicare Risk Medical Costs PMPM No more than + 6 percent
</TABLE>
Page 4 of 9
<PAGE> 5
<TABLE>
<S> <C>
Commercial Risk Medical Costs PMPM No more than + 4 percent
</TABLE>
For purposes of computing performance in the year 2000, the targeted percentage
rates of change shall be applied to a base equal to the targeted performance
levels for 1999. For purposes of computing performance in the year 2001, the
targeted percentage rates of change shall be applied to a base equal to the
targeted performance levels for 2000.
5. CALCULATION OF TOTAL PERCENTAGE OF TARGET ACHIEVED. For each of the
calendar years 1999, 2000 and 2001, the Total Percentage of Target Achieved
shall be calculated as follows:
A. In each Area of Performance (except Medical Costs PMPM),
the actual level of performance for the year shall be
divided by the targeted level of performance for that year
to yield the Percentage of Target Achieved for that Area of
Performance.
B. In the Medical Costs PMPM Area of Performance, the actual
level of performance for the year in each Sub-Area of
Performance shall first be divided by the targeted level of
performance for that Sub-Area. Since the targets for these
Sub-Areas are based on limiting the growth in medical
costs, the percentage so obtained will then be adjusted as
follows (unless it equals One Hundred Percent (100%)) to
yield the Percentage of Target for that Sub-Area:
(1) If the percentage so obtained is over One Hundred
Percent (100%), the percentage amount over One
Hundred Percent (100%) will be subtracted from One
Hundred Percent (100%).
(2) If the percentage so obtained is less then One
Hundred Percent (100%), the percentage amount less
than One Hundred Percent (100%) will be added to One
Hundred Percent (100%).
The Percentage of Target for each Sub-Area so obtained
shall then be multiplied by the weight assigned to that
Sub-Area to yield the Weighted Percentage achieved for that
Sub-Area. The Weighted Percentages achieved for the two
Sub-Areas shall then be added to obtain the overall
Percentage of Target Achieved for the Medical Costs PPM
Area of Performance.
C. Any Percentage of Target Achieved for an Area of
Performance which is less than Zero Percent (0%) shall be
considered to be Zero Percent (0%). Any Percentage of
Target Achieved for an Area of Performance that is greater
than One Hundred Fifty Percent (150%) of the target shall
be considered to be One Hundred Fifty Percent (150%).
D. The percentage weight assigned to each Area of Performance
shall then be multiplied by the Percentage of Target
Achieved for that Area of
Page 5 of 9
<PAGE> 6
Performance to yield the Weighted Percentage of Target
Achieved for that Area of Performance for that year.
E. The Weighted Percentage of Target achieved for each Area of
Performance shall then be added to yield the Total
Percentage of Target Achieved for that year in all Areas of
Performance.
6. CALCULATION OF LONG TERM INCENTIVE COMPENSATION. For each of the years
1999, 2000 and 2001, Executive shall be eligible to earn from $250,000 up to
$1,000,000 in long term incentive compensation, depending on the Total
Percentage of Target Achieved for that year in all Areas of Performance, as
follows:
<TABLE>
<CAPTION>
TOTAL PERCENTAGE OF TARGET ACHIEVED AMOUNT
----------------------------------- ------
<S> <C>
At least 80 percent but less than 81 percent $ 250,000
At least 81 percent but less than 82 percent $ 275,000
At least 82 percent but less than 83 percent $ 300,000
At least 83 percent but less than 84 percent $ 325,000
At least 84 percent but less than 85 percent $ 350,000
At least 85 percent but less than 86 percent $ 380,000
At least 86 percent but less than 87 percent $ 410,000
At least 87 percent but less than 88 percent $ 440,000
At least 88 percent but less than 89 percent $ 470,000
At least 89 percent but less than 90 percent $ 500,000
At least 90 percent but less than 91 percent $ 550,000
At least 91 percent but less than 92 percent $ 600,000
At least 92 percent but less than 93 percent $ 650,000
At least 93 percent but less than 94 percent $ 700,000
At least 94 percent but less than 95 percent $ 750,000
At least 95 percent but less than 96 percent $ 800,000
At least 96 percent but less than 97 percent $ 850,000
</TABLE>
Page 6 of 9
<PAGE> 7
<TABLE>
<S> <C>
At least 97 percent but less than 98 percent $ 900,000
At least 98 percent but less than 99 percent $ 950,000
At least 99 percent through 100 percent $1,000,000
</TABLE>
Executive will not earn any long term incentive compensation if the Total
Percentage of Target Achieved is less than 80 percent. There will be no increase
in the amount of long term incentive compensation payable hereunder for a Total
Percentage of Target Achieved that is greater than 100 percent. REGARDLESS OF
THE TOTAL PERCENTAGE OF TARGET ACHIEVED, EXECUTIVE WILL NOT BE ELIGIBLE TO EARN
ANY LONG TERM INCENTIVE COMPENSATION IN ANY YEAR UNLESS THE EMPLOYER ACHIEVES AT
LEAST 80% OF THE TARGETED PERCENTAGE RATE OF INCREASE IN THE EARNINGS PER SHARE
AREA OF PERFORMANCE FOR THAT YEAR. Long term incentive compensation for which
Executive is eligible hereunder shall be considered earned on January 1, 2000
(for the 1999 performance year), on January 1, 2001 (for the 2000 performance
year) and on January 1, 2002 (for the 2001 performance year), respectively.
7. PAYMENT OF EARNED LONG TERM INCENTIVE COMPENSATION. Except as
otherwise provided herein, any long term incentive compensation earned will be
paid on the first business day in April of the year following the calendar year
on which it is based, i.e. incentive compensation earned for the year 1999 will
be paid on April 3, 2000, incentive compensation earned for the year 2000 will
be paid on April 2, 2001 and incentive compensation earned for the year 2001
will be paid on April 1, 2002. Payment shall be made in cash, less required
withholdings.
8. FORFEITURE OF EARNED LONG TERM INCENTIVE COMPENSATION. If the
employment of Executive with Employer is terminated prior to the date of payment
(a) by Employer for Good Cause, as defined in Section 25 of the Employment
Agreement, or (b) by Executive for any reason other than Good Reason, as defined
in Section 25 of the Employment Agreement, then Executive shall forfeit any
right to payment of such earned long term incentive compensation.
9. ELIGIBILITY TO EARN LONG TERM INCENTIVE COMPENSATION AFTER
TERMINATION. If, prior to the date on which any long term incentive compensation
is earned pursuant to paragraph 6 above, the employment of Executive is
terminated (a) by Employer for any reason other than Good Cause, as defined in
Section 25 of the Employment Agreement, or (b) by Executive for Good Reason, as
defined in Section 25 of the Employment Agreement, then Executive shall remain
eligible to earn and be paid a portion of the long term incentive compensation
for the performance year in which such termination occurs, based on the
performance targets set forth herein, pro-rata based on the percent of the
performance year for which he was employed.
10. CHANGE IN CONTROL. In the event that there is a change in control of
Employer, as defined in paragraph 25(c) of the Employment Agreement, Executive
shall be paid in full for any earned long term incentive compensation, and shall
be paid the following percentage of the maximum amount of any long term
incentive compensation not yet earned:
Page 7 of 9
<PAGE> 8
<TABLE>
CHANGE OF CONTROL YEAR PERCENTAGE
---------------------- ----------
<S> <C>
1999 50%
2000 75%
2001 100%
</TABLE>
All such payments will be made at the time of closing of the transaction giving
rise to the change in control.
11. EXECUTIVE ASSIGNMENT. No interest of Executive or his spouse or any
other beneficiary under this Amendment to Employment Agreement, or any right to
receive any payment or distribution hereunder, shall be subject in any manner to
sale, transfer, assignment, pledge, attachment, garnishment, or other alienation
or encumbrance of any kind, nor may such interest or right to receive a payment
or distribution be taken, voluntarily or involuntarily, for the satisfaction of
the obligations or debts of, or other claims against, Executive or his spouse or
other beneficiary, including claims for alimony, support, separate maintenance,
and claims in bankruptcy proceedings.
12. DEATH. If Executive dies during the term of this Agreement all long
term incentive compensation amounts earned pursuant to paragraph 7, above, prior
to his death shall be paid to his surviving spouse. On the death of the survivor
of Executive and his spouse, no further long term incentive compensation amounts
will be paid.
13. BENEFITS UNFUNDED. All rights of Executive and his spouse or other
beneficiary under this Amendment to Employment Agreement shall at all times be
entirely unfunded and no provision shall at any time be made with respect to
segregating any assets of Employer for payment of any amounts due hereunder.
Neither Executive nor his spouse or other beneficiary shall have any interest in
or rights against any specific assets of Employer, and Executive and his spouse
or other beneficiary shall have only the rights of a general unsecured creditor
of Employer.
14. NOTICES. Any notice required or permitted to be given under this
Amendment to Employment Agreement shall be sufficient if in writing and sent by
registered or certified mail to his residence in the case of Executive, or to
its principal office in the case of the Employer and the date of receipt shall
be deemed the date which such notice has been provided.
15. WAIVER OF BREACH. The waiver by either party of any provision of this
Amendment to Employment Agreement shall not operate or be construed as a waiver
of any subsequent breach by the other party.
16. ASSIGNMENT. The rights and obligations of the Employer under this
Amendment to Employment Agreement shall inure to the benefit of and shall be
binding upon the successors and assigns of the Employer, subject to the
provisions of paragraph 10, above. The Executive acknowledges that the services
to be rendered by him are unique and personal, and Executive may not assign any
of his rights or delegate any of his duties or obligations under this Amendment
to Employment Agreement.
Page 8 of 9
<PAGE> 9
17. ENTIRE AGREEMENT. This instrument contains the entire agreement of
the parties and supersedes all other prior agreements, employment contracts and
understandings, both written and oral, express or implied with respect to the
subject matter of this Amendment to Employment Agreement and may not be changed
orally but only by an agreement in writing signed by the party against whom
enforcement of any waiver, change, modification, extension or discharge is
sought.
18. APPLICABLE LAW. This Amendment to Employment Agreement shall be
governed by the laws of the State of Maryland, without giving effect to the
principles of conflicts of law thereof.
19. HEADINGS. The sections, subjects and headings of this Amendment to
Employment Agreement are inserted for convenience only and shall not affect in
any way the meaning or interpretation of this Agreement.
20. COUNTERPARTS. This Amendment to Employment Agreement may be executed
in counterparts, each of which shall be deemed an original.
21. SEVERABILITY. In the event any provision of this Amendment to
Employment Agreement is held illegal or invalid, the remaining provisions of
this Amendment to Employment Agreement shall not be affected thereby.
IN WITNESS WHEREOF, the parties have executed this Amendment to
Employment Agreement on the day and year first written above.
/s/ Thomas McDonough
-------------------------------
Thomas McDonough
COVENTRY HEALTH CARE INC
By: /s/ Allen F. Wise
-------------------------------
Allen F. Wise
President and Chief Executive Officer
Page 9 of 9
<PAGE> 1
EXHIBIT 10.2
THIS WARRANT AND THE SHARES UNDERLYING THIS WARRANT HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933 OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS.
THIS WARRANT AND THE SHARES UNDERLYING THIS WARRANT MAY NOT BE SOLD, ASSIGNED,
TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
AND ANY APPLICABLE STATE SECURITIES OR BLUE SKY LAWS OR AN EXEMPTION FROM THE
REGISTRATION REQUIREMENTS THEREOF. IN ADDITION, THIS WARRANT MAY NOT BE SOLD,
ASSIGNED, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT
UPON THE CONDITIONS SPECIFIED IN THIS WARRANT, AND NO SALE, ASSIGNMENT,
TRANSFER, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS WARRANT SHALL BE
VALID OR EFFECTIVE UNLESS AND UNTIL SUCH CONDITIONS SHALL HAVE BEEN COMPLIED
WITH.
NO. W00052 Right to Purchase 50,000
Shares of Common Stock
COMMON STOCK PURCHASE WARRANT
THIS CERTIFIES THAT, subject to the terms and conditions set forth
herein, JOHN W. CAMPBELL ("Holder") is entitled to purchase from COVENTRY HEALTH
CARE, INC., a Delaware corporation (the "Company"), at any time and from time to
time, in whole or in part, during the period specified herein, up to Fifty
Thousand (50,000) fully paid and nonassessable shares of the Company's Common
Stock, par value $.01 per share (the "Warrant Shares"), at an exercise price of
$7.625 per share (the "Exercise Price"), which is the market price of the
Company's Common Stock on December 21, 1998, the date the Company executed an
agreement for the provision of legal services with Epstein Becker & Green, P.C.
("EBG") and agreed to the issuance of this Warrant. The Warrant Shares and the
Exercise Price are subject to adjustment as provided in Section 7 hereof.
This Warrant is subject to the following terms, provisions, and
conditions:
1. Manner of Exercise; Issuance of Certificates; Payment for Warrant
Shares. Subject to the provisions hereof, including Section 2 hereof, this
Warrant may be exercised by the Holder hereof, in whole or in part, by the
surrender of this Warrant, together with a completed Exercise Agreement in the
form attached hereto, to the Company during normal business hours on any
business day at the Company's principal executive offices (or such other office
or agency of the Company as it may designate by notice to the Holder hereof),
and upon payment to the Company in cash or by certified or official bank check
of the Exercise Price for the Warrant Shares specified in said Exercise
Agreement. In addition, to the extent and when from time to time the Company
generally makes available to its senior management the ability to do a cashless
exercise of options issued under the Company's Amended and Restated 1998 Stock
Incentive Plan, the Holder shall be entitled to do a cashless exercise of this
Warrant on substantially similar terms. The Warrant Shares so purchased shall be
deemed to be issued to the Holder or said Holder's designee as the record owner
of such shares as of the close of business on the date on which this Warrant
shall have been surrendered for exercise, the completed Exercise Agreement
delivered, and payment made for the Warrant Shares being purchased as aforesaid.
Certificates for the Warrant Shares so purchased,
<PAGE> 2
representing the aggregate number of shares specified in said Exercise
Agreement, shall be delivered to the holder hereof within a reasonable time,
not exceeding seven (7) business days, after this Warrant shall have been so
exercised. The certificates so delivered shall be in such denominations as may
be requested by the Holder hereof and shall be registered in the name of said
Holder or such other name as shall be designated by said Holder. If this
Warrant shall have been exercised only in part, then, unless this Warrant has
expired, the Company shall, at its expense, at the time of delivery of said
certificates, deliver to the holder a new Warrant representing the number of
shares with respect to which this Warrant shall not then have been exercised.
2. Period of Exercise. This Warrant is exercisable as follows: 16,667
Warrant Shares become exercisable on December 31, 1999; 16,667 Warrant Shares
become exercisable on December 31, 2000; and 16,666 Warrant Shares become
exercisable on December 31, 2001. This Warrant terminates at the close of
business on January 4, 2009, subject to earlier termination as provided herein,
at which time this Warrant shall expire and be of no further force and effect.
3. Certain Agreements of the Company. The Company hereby covenants and
agrees as follows:
(a) Warrant Shares to be Fully Paid. All Warrant Shares will, upon
issuance, be validly issued, fully paid, nonassessable and free
from all taxes, liens, and charges.
(b) Reservation of Shares. During the period within which this
Warrant may be exercised, the Company will at all times have
authorized, and reserved for the purpose of issuance upon
exercise of this Warrant, a sufficient number of shares of Common
Stock to provide for the exercise of this Warrant.
(c) Successors and Assigns. This Warrant will be binding upon any
entity succeeding to the Company by merger, consolidation, or
acquisition of all or substantially all of the Company's assets.
(d) Registration of Warrant Shares. The Company will use its best
efforts to register the Warrant Shares with the Securities and
Exchange Commission on or before December 31, 1999.
4. Non-Employee Compensation. The value realized by the Holder on the
exercise of the Warrant is considered to be non-employee compensation and the
Company will issue a Form 1099 to the Holder reporting any such compensation
attributed to or received by the Holder.
5. No Rights or Liabilities as a Shareholder. This Warrant shall not
entitle the holder hereof to any voting rights or other rights as a shareholder
of the Company. No provision of this Warrant, in the absence of affirmative
action by the holder hereof to purchase Warrant Shares, and no mere enumeration
herein of the rights or privileges of the holder hereof, shall give rise to any
liability of such holder for the Exercise Price or as a shareholder of the
Company, whether such liability is asserted by the Company or by creditors of
the Company.
6. Transfer, Exchange, and Replacement of Warrants and Warrant
Shares.
(a) Restriction on Transfer. Anything in this Warrant to the
contrary notwithstanding, this Warrant (and any Warrant for
which this Warrant may
2
<PAGE> 3
be exchanged or replaced) may not be transferred or assigned,
except (i) by the Holder to a member of his Immediate Family
(defined below) or a trust for the benefit of the Holder or a
member of his Immediate Family, or (ii) by will or pursuant to
the laws of descent and distribution; provided, however, that
any transfer or assignment shall be subject to the conditions
set forth in Section 6(f) hereof. Until due presentment for
registration of transfer on the books of the Company, the
Company may treat the registered holder hereof as the owner and
holder hereof for all purposes, and the Company shall not be
affected by any notice to the contrary. For purposes of this
paragraph, "Immediate Family" means any child, stepchild,
grandchild, parent, stepparent, grandparent, spouse, sibling,
mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law, or sister-in-law, and shall include adoptive
relationships.
(b) Warrant Exchangeable for Different Denominations. Subject to
Section 6(a) hereof, this Warrant is exchangeable, upon the
surrender hereof by the holder hereof at the office or agency of
the Company referred to in Section 6(e) hereof, for new Warrants
of like tenor representing in the aggregate the right to purchase
the number of Warrant Shares which may be purchased hereunder,
each of such new Warrants to represent the right to purchase such
number of Warrant Shares as shall be designated by said holder
hereof at the time of such surrender.
(c) Replacement of Warrant. Upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction, or
mutilation of this Warrant and, in the case of any such loss,
theft, or destruction, upon delivery of an indemnity agreement
reasonably satisfactory in form and amount to the Company, or, in
the case of any such mutilation, upon surrender and cancellation
of this Warrant, the Company, at its expense, will execute and
deliver, in lieu thereof, a new Warrant of like tenor.
(d) Cancellation. Upon the surrender of this Warrant in connection
with any transfer, exchange, or replacement as provided in this
Section 6, this Warrant shall be promptly canceled by the
Company.
(e) Register. The Company shall maintain, at its principal executive
offices (or such other office or agency of the Company as it may
designate by notice to the holder hereof), a register for this
Warrant, in which the Company shall record the name and address
of the person in whose name this Warrant has been issued, as well
as the name and address of each transferee and each prior owner
of this Warrant.
(f) Investment Representation. By acceptance of this Warrant, the
holder hereof hereby represents that: (i) such holder
understands that neither this Warrant nor the Warrant Shares
issuable upon exercise hereof have been registered under the
Securities Act of 1933, as amended (the "Securities Act") or any
state securities laws and, in addition to the other restrictions
on transfer set forth in this Warrant, neither this Warrant nor
the Warrant Shares issuable upon exercise hereof may be
transferred in the absence of an effective registration
statement under the Securities Act and any applicable state
securities laws or an exemption from the registration
requirements thereof, and (ii) such holder is acquiring this
Warrant for investment purposes only, and not with a view to the
resale or distribution of this Warrant or the Warrant Shares.
Following the exercise of this Warrant, the holder shall not
3
<PAGE> 4
transfer the Warrant Shares except pursuant to an effective
registration statement under the Securities Act and any
applicable state securities laws or blue sky laws unless (x) the
holder of this Warrant furnishes to the Company a written
opinion of counsel, which opinion and counsel are acceptable to
the Company, to the effect that such exercise, transfer, or
exchange may be made without registration under the Securities
Act and under applicable state securities or blue sky laws and
(y) the holder or transferee executes and delivers to the
Company an investment letter in form and substance acceptable to
the Company.
7. Adjustments Upon Changes in Common Stock. In the event the Company
shall effect a split of the Common Stock or dividend payable in Common Stock, or
in the event the outstanding Common Stock shall be combined into a smaller
number of shares, the maximum number of Warrant Shares for which this Warrant
may be exercised shall be decreased or increased proportionately and the
Exercise Price shall be decreased or increased proportionately so that the
aggregate Exercise Price for all of the Warrant Shares shall remain the same as
immediately prior to such split, dividend or combination.
In the event of a reclassification of the Common Stock not covered by
the foregoing, or in the event of a liquidation or reorganization (including a
merger, consolidation, spin-off or sale of assets) of the Company or a parent or
subsidiary of the Company, the Board of Directors of the Company (the "Board")
shall make such adjustments, if any, as it may deem appropriate in its sole
discretion in the number, Exercise Price and kind of shares covered by the
unexercised portions of this Warrant. The provisions of this Section shall only
be applicable if, and only to the extent that, the application thereof does not
conflict with a valid governmental statute, regulation or rule.
8. Effects of Change In Control
(a) Impact of Event. In the event of: (1) a "Change in Control" as
defined in Section8(b); or (2) a "Potential Change in Control" as
defined in Section 8(c), but only if and to the extent so
determined by the Board of Directors of the Company (the "Board")
after grant (subject to any right of approval expressly reserved
by the Board at the time of such determination),
(i) This Warrant to the extent not previously exercisable and
vested shall become fully exercisable and vested.
(ii) The value of this Warrant to the extent vested and
exercisable, shall, unless otherwise determined by the Board
in its sole discretion prior to any Change in Control, be
cashed out on the basis of the "Change in Control Price" as
defined in Section 8(d) as of the date such Change in
Control or such Potential Change in Control is determined to
have occurred or such other date as the Board may determine
prior to the Change in Control.
(b) Definition of Change in Control. For purposes of Section 8(a), a
"Change in Control" means the happening of any of the following:
(i) any person or entity, including a "group" as defined in
Section 13(d)(3) of the Securities Exchange Act, other than
the Company or a wholly-owned subsidiary thereof or any
employee benefit plan of the Company or any of its
4
<PAGE> 5
Subsidiaries, becomes the beneficial owner of the Company's
securities having 35% or more of the combined voting power
of the then outstanding securities of the Company that may
be cast for the election of directors of the Company (other
than as a result of an issuance of securities initiated by
the Company in the ordinary course of business or other
than transactions which are approved by a majority of the
Board); or
(ii) as the result of, or in connection with, any cash tender or
exchange offer, merger or other business combination, sale
of assets or contested election, or any combination of the
foregoing transactions, less than a majority of the combined
voting power of the then outstanding securities of the
Company or any successor corporation or entity entitled to
vote generally in the election of the directors of the
Company or such other corporation or entity after such
transactions are held in the aggregate by the holders of the
Company's securities entitled to vote generally in the
election of directors of the Company immediately prior to
such transaction; or
(iii)during any period of two consecutive years, individuals who
at the beginning of any such period constituted the Board
cease for any reason to constitute at least a majority
thereof, unless the election, or the nomination for election
by the Company's shareholders, of each director of the
Company first elected during such period was approved by a
vote of at least two-thirds of the directors of the Company
then still in office who were directors of the Company at
the beginning of any such period.
(c) Definition of Potential Change in Control. For purposes of
Section 8(a), a "Potential Change in Control" means the happening
of any one of the following:
(i) The approval by shareholders of an agreement by the Company,
the consummation of which would result in a Change in
Control of the Company as defined in Section 8(b); or
(ii) The acquisition of beneficial ownership, directly or
indirectly, by any entity, person or group (other than the
Company or a subsidiary or any Company employee benefit plan
(including any trustee of such plan acting as such trustee))
of securities of the Company representing 5% or more of the
combined voting power of the Company's outstanding
securities and the adoption by the Committee of a resolution
to the effect that a Potential Change in Control of the
Company has occurred for purposes of the Company's Amended
and Restated 1998 Stock Incentive Plan.
(d) Change in Control Price. For purposes of this Section 8, "Change
in Control Price" means the highest price per share paid in any
transaction
5
<PAGE> 6
reported on the Nasdaq National Market or such other
exchange or market as is the principal trading market for the
Common Stock, or paid or offered in any bona fide transaction
related to a Potential or actual Change in Control of the
Company at any time during the 60-day period immediately
preceding the occurrence of the Change in Control (or, where
applicable, the occurrence of the Potential Change in Control
event), in each case as determined by the Board or, where
applicable, the date on which a cash out occurs under Section
8(a)(ii).
9. Termination of Warrant. In the event that (i) the contractual
relationship between EBG and the Company or any successor of the Company is
terminated other than in connection with a Change In Control or Potential Change
in Control under Section 8, or (ii) the Holder ceases to work for EBG or (iii)
the Holder no longer renders services to the Company as EBG's partner in charge
of the Company's legal affairs, the Holder may exercise this Warrant, to the
extent he was entitled to do so at the effective date of the occurrence of any
of the foregoing events, at any time within ninety (90) days after the
occurrence of any such event but in no event after the expiration of this
Warrant (i.e., the expiration of ten years from the date of grant or such
earlier expiration date as may be provided in this Warrant); provided, however,
if the occurrence of any of the foregoing events was due to "Cause" attributable
to the actions of Holder, this Warrant shall immediately lapse and expire. For
purposes of this Warrant, "Cause" means (i) a felony conviction or the failure
to contest prosecution for a felony, or (ii) willful misconduct or dishonesty,
which is directly and materially harmful to the business or reputation of the
Company or any subsidiary or affiliate.
10. Disability or Retirement. If Holder's services rendered to the
Company on behalf of EBG are terminated by reason of Holder's disability or
early or normal retirement from EBG, in accordance with EBG's policies and
procedures, Holder may exercise that portion of this Warrant which was
exercisable by him at the date of such termination at any time within three (3)
years of the date of such termination; provided, however, that such exercise
occurs within ten (10) years of the date this Warrant was granted to Holder or
such earlier expiration date as may be provided in this Warrant.
11. Death. If Holder dies during the term of the contractual
relationship between EBG and the Company, and Holder is rendering services to
the Company as EBG's partner in charge of the Company's legal affairs, that
portion of this Warrant which was exercisable by Holder at the date of his death
may be exercised by the legal representative of Holder's estate or the legatee
or legatees under Holder's will for a period of twelve (12) months from the date
of Holder's death, but in no event after ten (10) years from the date this
Warrant was granted to Holder or such earlier expiration date as may be provided
in this Warrant.
12. Notices. All notices, requests, and other communications required or
permitted to be given or delivered hereunder to the holder of this Warrant shall
be in writing, and shall be personally delivered, or shall be sent by certified
or registered mail, postage prepaid and addressed to such holder at the address
shown for such holder on the books of the Company, or at such other address as
shall have been furnished to the Company by notice from such holder. All
notices, requests, and other communications required or permitted to be given or
delivered hereunder to the Company shall be in writing, and shall be personally
delivered, or shall be sent by certified or registered mail, postage prepaid and
addressed, to the office of the Company at 6705 Rockledge Drive, Suite 900,
Bethesda, MD 20817, Attention: President (or Secretary), or at such other
address as shall have been furnished to the holder of this Warrant by notice
from the Company. Any such notice, request, or other communication may be sent
by telegram, telex, or telecopy, but shall in such case be subsequently
confirmed by a writing personally delivered or sent by certified or registered
mail as provided above. All
6
<PAGE> 7
notices, requests, and other communications shall be deemed to have been given
either at the time of the delivery thereof to (or the receipt by, in the case
of a telegram, telex or telecopy) the person entitled to receive such notice at
the address of such person for purposes of this Section 12, or, if mailed, at
the completion of the third (3rd) full day following the time of such mailing
thereof to such address, as the case may be.
13. Governing Law. This Warrant shall be governed by and construed and
enforced in accordance with the laws of the State of Delaware.
14. Miscellaneous.
(a) Amendments. This Warrant and any provision hereof may not be
changed, waived, discharged, or terminated, except by an
instrument in writing signed by the party (or any predecessor
interest thereof) against which enforcement of the same is
sought.
(b) Descriptive Headings. The descriptive headings of the several
paragraphs of this Warrant are inserted for purposes of reference
only, and shall not affect the meaning or construction of any of
the provisions hereof.
IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by
its duly authorized officer under its corporate seal, attested by its duly
authorized officer, as of the 4th day of January, 1999.
COVENTRY HEALTH CARE, INC.
By: /s/ Allen F. Wise
---------------------------------
Allen F. Wise
President and Chief Executive Officer
[CORPORATE SEAL]
Attest:
/s/ Shirley R. Smith
- ----------------------------
Shirley R. Smith
Secretary
7
<PAGE> 8
EXERCISE AGREEMENT
Dated: _____________, _______
To: _____________________
The undersigned, pursuant to the provisions set forth in the within
Warrant No. W00052, hereby agrees to purchase _________ shares of Common Stock
of Coventry Health Care, Inc. covered by such Warrant, and makes payment
herewith in full therefor at the price per share provided by such Warrant in
cash or by certified or official bank check in the amount of $_______________.
Please issue a certificate or certificates for such shares of Common Stock in
the name of (and pay cash for any fractional share(s)) to the following:
Name:
--------------------------------
SS No./ Tax ID No.:
--------------------------------
Address:
--------------------------------
--------------------------------
--------------------------------
Signature*:
--------------------------------
--------
* The above signature should correspond exactly with the name on the
face of the within Warrant.
If the number of Warrant Shares exercised herein shall not be all of the shares
purchasable under the within Warrant, a new Warrant is to be issued in the name
of the above signatory covering the balance of the Warrant Shares purchasable
under the within Warrant, less any fraction of a share paid to the holder in
cash.
8
<PAGE> 1
Exhibit 11.1
Coventry Health Care, Inc.
Computation of Net Earnings Per Share
(in thousands, except for per share amounts)
<TABLE>
<CAPTION>
Quarter ended September 30, 1999
-------------------------------------
Net Income Shares Per Share
(Numerator) (Denominator) Amount
-------------------------------------
<S> <C> <C> <C>
Basic EPS $10,970 59,102 $0.19
Effect of Dilutive Securities
Options and warrants 517
Convertible preferred stocks 1,717
Convertible notes 2,993
-------------------------------------
Diluted EPS $10,970 64,329 $0.17
-------------------------------------
</TABLE>
<TABLE>
<CAPTION>
Quarter ended September 30, 1998
-------------------------------------
Net Income Shares Per Share
(Numerator) (Denominator) Amount
-------------------------------------
<S> <C> <C> <C>
Basic EPS $5,068 58,785 $0.09
Effect of Dilutive Securities:
Options and warrants 114
-------------------------------------
Diluted EPS $5,068 58,899 $0.09
</TABLE>
<TABLE>
<CAPTION>
Nine months ended September 30, 1999
----------------------------------------
Net Income Shares Per Share
(Numerator) (Denominator) Amount
----------------------------------------
<S> <C> <C> <C>
Basic EPS $28,420 58,972 $0.48
Effect of Dilutive Securities
Options and warrants 663
Convertible preferred stocks 605
Convertible notes 4,035
Interest on convertible notes 848
----------------------------------------
Diluted EPS $29,268 64,275 $0.46
----------------------------------------
</TABLE>
<TABLE>
<CAPTION>
Nine months ended September 30, 1998
------------------------------------------
Net Loss Shares Per Share
(Numerator) (Denominator) Amount
------------------------------------------
<S> <C> <C> <C>
Basic EPS ($17,981) 50,242 ($0.36)
</TABLE>
1
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF COVENTRY HEALTH CARE, INC. FOR THE THREE MONTHS ENDED
SEPTEMBER 30, 1999 AND IS QUALIFIED IN ITS ENTIRELY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JUL-01-1999
<PERIOD-END> SEP-30-1999
<CASH> 185,409
<SECURITIES> 364,218
<RECEIVABLES> 65,270
<ALLOWANCES> (13,466)
<INVENTORY> 0
<CURRENT-ASSETS> 412,105
<PP&E> 93,354
<DEPRECIATION> (55,500)
<TOTAL-ASSETS> 1,014,997
<CURRENT-LIABILITIES> 464,075
<BONDS> 0
0
47
<COMMON> 596
<OTHER-SE> 510,569
<TOTAL-LIABILITY-AND-EQUITY> 1,014,997
<SALES> 0
<TOTAL-REVENUES> 529,889
<CGS> 0
<TOTAL-COSTS> 518,498
<OTHER-EXPENSES> (7,838)
<LOSS-PROVISION> 247
<INTEREST-EXPENSE> 33
<INCOME-PRETAX> 19,196
<INCOME-TAX> 8,226
<INCOME-CONTINUING> 10,970
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 10,970
<EPS-BASIC> .19
<EPS-DILUTED> .17
</TABLE>
